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COMPREHENSIVE INVITED REVIEW
The Emerging Roles of Nicotinamide Adenine
Dinucleotide Phosphate Oxidase 2 in Skeletal
Muscle Redox Signaling and Metabolism
Carlos Henrı´quez-Olguı´n,1,2 Susanna Boronat,3 Claudio Cabello-Verrugio,4–6
Enrique Jaimovich,2 Elena Hidalgo,3 and Thomas E. Jensen1
Abstract
Significance: Skeletal muscle is a crucial tissue to whole-body locomotion and metabolic health. Reactive oxygen
species (ROS) have emerged as intracellular messengers participating in both physiological and pathological ad-
aptations in skeletal muscle. A complex interplay between ROS-producing enzymes and antioxidant networks exists
in different subcellular compartments of mature skeletal muscle. Recent evidence suggests that nicotinamide adenine
dinucleotide phosphate (NADPH) oxidases (NOXs) are a major source of contraction- and insulin-stimulated
oxidants production, but they may paradoxically also contribute to muscle insulin resistance and atrophy.
Recent Advances: Pharmacological and molecular biological tools, including redox-sensitive probes and
transgenic mouse models, have generated novel insights into compartmentalized redox signaling and suggested
that NOX2 contributes to redox control of skeletal muscle metabolism.
Critical Issues: Major outstanding questions in skeletal muscle include where NOX2 activation occurs under
different conditions in health and disease, how NOX2 activation is regulated, how superoxide/hydrogen per-
oxide generated by NOX2 reaches the cytosol, what the signaling mediators are downstream of NOX2, and the
role of NOX2 for different physiological and pathophysiological processes.
Future Directions: Future research should utilize and expand the current redox-signaling toolbox to clarify the
NOX2-dependent mechanisms in skeletal muscle and determine whether the proposed functions of NOX2 in
cells and animal models are conserved into humans. Antioxid. Redox Signal. 31, 1371–1410.
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Skeletal muscle constitutes*40% of total body massand plays a crucial role in maintaining locomotion, met-
abolic health, and, thus, ultimately quality of life (386). Ex-
ternal factors, such as diet and physical activity, as well as
internal factors, such as gender, aging, and genetic muscle
diseases, have been demonstrated to have a profound effect
on both muscle function and whole-body homeostasis (55).
Unravelling the molecular mechanisms responsible for the
adaptive responses may allow us to identify novel pharma-
cological targets to treat muscle diseases (118).
Reactive oxygen species (ROS) are proposed to be molec-
ular regulators of the physiological and pathological adapta-
tion of skeletal muscle (286). ROS are continuously generated
and buffered in skeletal muscle both at rest and in response to
various stressors (286). A complex interplay between ROS-
producing enzymes and antioxidant networks exists in differ-
ent subcellular compartments of mature skeletal muscle (307),
allowing for highly compartmentalized signaling by specific
hydrogen peroxide (H2O2) and oxidation products. The re-
sulting changes in the myofiber redox state are emerging as
essential signal transduction elements linked to the regulation
of, for example, muscle metabolism, repair, and growth (286).
Nicotinamide adenine dinucleotide phosphate (NADPH)
oxidase (NOX) complexes were first described in phagocytic
cells, but have since been found to be expressed in many
nonimmune cell types, including different brain cells, endo-
thelial cells, hepatocytes, adipocytes, cardiomyocytes, skel-
etal muscle, and more (27). So far, NOXs are the only enzyme
family known to produce ROS as their primary function, in
contrast to other enzymes that generate ROS as byproducts
of their catalytic functions. It has been shown that skeletal
muscle expresses at least two isoforms, NOX2 and NOX4, in
different subcellular compartments (144).
This review will focus on the many emerging connections
between NOX2-dependent redox signaling and metabolic
homeostasis in skeletal muscle and try to reconcile the several
seemingly contradicting paradigms regarding NOX2 as being
both a beneficial and a detrimental player in this context. First,
we will provide an overview of fundamental mechanisms in
general redox biochemistry to introduce emerging redox-
signaling concepts to nonredox specialists, after which we will
review the generic NOX2 complex expression and regulation,
considering the relevance to skeletal muscle when possible.
Then, the literature regarding the physiological regulation of
NOX2 and its downstream effects in skeletal muscle will be
discussed. Lastly, the involvement of NOX2 in various skel-
etal muscle disease states will be covered.
II. General Introduction to Redox Signaling
A. Regulation of signaling cascades by H2O2—
reversible oxidation of cysteine residues
ROS clearly display signaling or regulatory functions, in
addition to their described capacity to damage biomolecules
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and induce damage. Along with this idea, the redox biology
community has developed the view that oxidants are re-
sponsible for oxidative damage, whereas signaling mecha-
nisms involve H2O2 or other two-electron oxidants (383).
Indeed, H2O2 has some features that make it a good signaling
molecule; it is a robust two-electron oxidant, with a standard
reduction potential (E¢o) of 1.32 V at pH 7.0 (382), and it is,
therefore, capable of oxidizing a wide range of substrates.
However, in contrast to other two-electron reactive species,
the reactions of H2O2 have to overcome a high activation
energy barrier to release its oxidizing power and, therefore,
they are kinetically rather than thermodynamically driven.
This reactivity, restricted to very few biological molecules at
an appreciable rate, for example, thiols in proteins, provides
the basis for a highly selective messenger.
As proposed by Brigelius-Flohe´ and Flohe´ (45), a real
redox signaling mechanism requires a primary signaling
molecule, a sensor, transducers, effectors, and reversion re-
actions to terminate the signaling cascade. Thus, H2O2 will
react in a specific, fast, and efficient manner with sensor
proteins containing redox switches, such as metal centers or
cysteine (Cys) residues (thiols); the reversible oxidation of
these redox moieties controls the activity of the sensor pro-
teins. The reactivity of Fe-S clusters toward redox-active
molecules and its role in signaling has been recently reviewed
(70). This section will only focus on H2O2 signaling mediated
by reversible Cys oxidation, and on the reduction by the
thioredoxin (Trx)/thioredoxin reductase (TXNRD) and glu-
taredoxin (Grx)/reduced glutathione (GSH)/GSH reductase
pathways, which reduce proteins containing reversibly oxi-
dized Cys using NADPH as the final electron donor (Fig. 1).
The oxidative modifications of Cys produced by H2O2
are summarized in Figure 2. Exposure of a Cys thiol (SH) to
low levels of H2O2 results in the formation of a sulfenic acid
(Cys-SOH) intermediate, which due to its high reactivity will
rapidly react with GSH (glutathionylation; Cys-SSG), with a
nearby Cys, to form an inter- or intramolecular disulfide bond
(295), or with adjacent amino groups, to form a cyclic sul-
fenamide. Larger doses of H2O2 will result in the oxidation of
Cys-SOH to sulfinic or sulfonic acid, modifications that are,
in general, irreversible (Fig. 2). It is now becoming apparent
that biological thiols can also exist in the form of hydro-
persulfide or polysulfide species (71, 157). They have a re-
duced pKa, which, in part, explains their enhanced
nucleophilic properties and one-electron reductant activity
FIG. 1. Trx- and Grx-dependent reduction pathways.
Trx and Grx can reduce different types of oxidized cysteine
residues and have a large spectrum of target peptides. Grx
and Trx are generally reduced by GSH and Trx reductase,
respectively. Finally, GSHR and TXNRD obtain their re-
ducing power from the pool of NADPH or NADH. Grx,
glutaredoxin; GSH, reduced glutathione; GSHR, glutathione
reductase; NADPH, nicotinamide adenine dinucleotide
phosphate; Trx, thioredoxin; TXNRD, thioredoxin reduc-
tase. Color images are available online.
FIG. 2. Oxidation states of a thiol group on H2O2-dependent oxidation. After being exposed to H2O2, thiol groups are
oxidized to a sulfenic acid form. This species is highly unstable, readily reacting with another proximal thiol or with GSH to
form a disulfide bond or a glutathionylated protein, respectively, or with adjacent nitrogen to form a sulfenamide. In the
presence of more H2O2, sulfenic acid can be further oxidized to sulfinic or sulfonic acid, which, in general, is an irreversible
modification that cannot be repaired within cells. Protein thiols in the form of hydropersulfide can be oxidized by H2O2,
leading to the intermediate formation of perthiosulfenic acid species. GSH, reduced glutathione; H2O2, hydrogen peroxide.
Color images are available online.
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compared with corresponding sulfhydryl species (34, 71,
157) and it has been proposed that they might represent im-
portant targets for H2O2, leading to the intermediate forma-
tion of perthiosulfenic acid species (143).
Laying aside the chemical nature of the thiol modification,
key factors that account for sensitivity and specificity in the
reaction of specific Cys residues with H2O2 and that, therefore,
define a true thiol switch are accessibility, intermediate half-
lives of disulfides, and sufficient reactivity of Cys thiols, the
latter given by the rate constant and concentration (82). These
parameters are determined by the protein environment, result-
ing in activated molecular geometries, particularly with regard
to the transition state, as well as appropriate redox potential,
pKa values of both the nucleophilic-Cys thiol and the leaving
group (OH- in the case of H2O2), and complementary surfaces
between signal molecules and interacting proteins (82, 108).
However, and despite theoretical predictions, there is a wide
range of reactivity of thiol-containing proteins toward H2O2
spanning several orders of magnitude, from the low 20 M-1 s-1
for some protein tyrosine phosphatases, such as protein tyrosine
phosphatase 1B (PTP1B) and SHP-2, to the high 107 M-1 s-1
for peroxiredoxin (Prx) 2 (384). More strikingly, the reactivity
toward peroxides of proteins proposed to be redox regulated
(such as phosphatases, kinases, and transcription factors that
are activated or inactivated by thiol oxidation for signaling
purposes) often falls in the range of mid-to-low intrinsic H2O2
reactivity (k& 101–102 M-1 s-1) (229) and they are expressed
at low levels. This moderate H2O2 reactivity should not be a
problem as long as cells require a slow response, or if the H2O2
transient signal lasts for a long time (229). However, if these
proteins are directly oxidized by H2O2, it is difficult to reconcile
a fast oxidation of low reactive thiols by nanomolar concen-
trations of H2O2 in the presence of abundant high-affinity H2O2
scavenger proteins such as Prxs.
There are currently two models to explain the mechanism
by which H2O2 is transduced to low-reactivity target proteins,
which are not mutually exclusive, and the occurrence of one
mechanism or the other could be influenced by the source of
H2O2 generation, duration, and cellular location. The pre-
dictions, experimental evidence, and open questions of these
two models have been recently reviewed (334), and they will
be summarized here briefly (Fig. 3A, B).
The first model consists of the direct oxidation of thiols in
redox-regulated proteins by H2O2 present in the environ-
ment that has diffused from the original intra- or extracel-
lular source (Fig. 3A). H2O2 is actually able to diffuse
through lipid membranes, but aquaporins (AQPNs) facili-
tate the passage of H2O2 across membranes (246). As
mentioned earlier, because of the higher H2O2 reactivity of
Prxs and GSH peroxidases (Gpxs), these H2O2 scavengers
are strong competitors of redox-regulated proteins, and they
need to be transiently inactivated by post-translational
modifications. Once the activity of Prxs has been temporally
and locally blocked, the accumulation of H2O2 may reach
concentrations in the micromolar range that now allow for
the direct oxidation of protein thiols with low H2O2 reac-
tivity (229). In support of this hypothesis, there are some
2-Cys-Prxs whose peroxidatic Cys are easily hyperoxidized
to sulfinic acid, inactivating their peroxidase activity. The
existence of sulfiredoxins, enzymes capable of specifically
reducing sulfinic acid forms in Prxs, also supports the role of
transient Prxs inactivation in H2O2 signaling (37). In addi-
tion to Prxs inactivation by hyperoxidation, inactivation by
phosphorylation is an alternative mechanism described for
Prx1. A comprehensive review regarding mammalian Prxs
regulation has been recently published (296). An interesting
concept related to Prxs inactivation is the localized accu-
mulation of H2O2, providing an additional means of target
selectivity. Only proteins that are recruited into high H2O2
microenvironments (e.g., in close proximity to H2O2 sources
or to inactivated Prxs or confined in compartments lacking
Prxs) would be oxidized. In favor of this idea, it is widely
accepted that the spatial distribution of H2O2 in cells and tis-
sues is not uniform; instead, substantial gradients exist both
from extracellular to intercellular and between subcellular
spaces (20, 228).
The second mechanism for H2O2 transduction postulated
as a ‘‘redox relay’’, proposes that Prxs and, to a lesser extent,
Gpxs do outcompete all other less reactive protein thiols and
transfer oxidized equivalents to redox-regulated target pro-
teins, constituting a two-component sensor system (Fig. 3B).
As opposed to the ‘‘direct oxidation’’ mechanism, Prxs are
the ‘‘true’’ sensors in the signaling pathway and enable pro-
tein oxidation rather than compete (385). According to this
FIG. 3. Mechanisms by which H2O2 could be transduced to low reactivity target proteins. Illustration of the two nonexclusive
mechanisms by which H2O2 is transduced to low reactivity target proteins and how reversibility is achieved. (A) Direct thiol
modification in redox sensitive proteins by H2O2. (B) Redox relay model, where peroxidase act as a H2O2 sensors and oxidizing
signaling proteins. Color images are available online.
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model, protein and thiol specificity can be explained by
protein–protein interactions that could be direct or facilitated
by scaffold protein as recently proposed in yeast (33). Again,
cell-specific localization of different combinations of Prxs,
scaffold, and target proteins conforms to additional speci-
ficity levels.
An additional level of complexity of the Prx (or Gpx)-based
redox relay model is based on the fact that the reaction of H2O2
with peroxidases during the scavenging cycle requires the re-
cycling by, and the concomitant oxidation of, Trxs. Oxidized
Prxs would accumulate only when TXNRD or NADPH
become transiently limiting or exhausted, transferring the oxi-
dizing equivalents to target signaling proteins (53). Alter-
natively, the accumulation of oxidized Trxs could directly
promote oxidation of the target signaling protein. Although no
direct biochemical thiol-disulfide exchange between an oxi-
dized Trx and a downstream target has been demonstrated,
several signal transduction pathways have been proposed to be
activated by oxidized Trx but not by reduced Trx [reviewed by
Berndt et al. (31) and Netto and Antunes (262)].
B. Reversibility of H2O2 signaling: reduction
of reversibly oxidized Cys residues in proteins
The two main reversible oxidative Cys modifications in-
volved in H2O2 signaling are sulfenic acid and disulfides. The
recycling/reduction of sensors and other oxidized proteins in
H2O2 signaling cascades containing these modifications de-
pends on the two major systems that cells are provided with to
regulate the thiol-disulfide status of proteins: the Trx and Grx
systems (Fig. 1). Trxs and Grxs are small oxidoreductases (9–
15 kDa) originally identified as hydrogen donors for ribonu-
cleotide reductase (150, 253). They are structurally similar
and rely on a Cys-X-X-Cys/Ser active site motif (Trx fold) to
reduce protein disulfides using a dithiol mechanism. In the
Trx, the dimeric flavoenzyme TXNRD reduces oxidized Trx
by using NADPH as the electron donor (397). Regarding the
Grx pathway, disulfide bonds in proteins can be reduced by a
dithiol mechanism, by which Grxs form mixed disulfides
with the protein. In addition, Grxs can catalyze the reduction
of mixed disulfides formed between protein Cys residues and
GSH (deglutathionylation) by using a so-called monothiol
mechanism that only requires the N-terminal Cys residue of
the Cys-X-X-Cys/Ser motif (82). Both processes require a
consequent series of reactions involving GSH, GSH reduc-
tase, and reduced cofactor (124). Crosstalk between these two
electron flow pathways is exemplified by mammalian Grx2,
characterized by the uncommon active site motif Cys–Ser–
Tyr–Cys (instead of the regular dithiol consensus Cys–Pro–
Tyr–Cys), that can receive electrons from TXNRD (167).
Although Grxs are the only oxidoreductases that are ca-
pable of reducing glutathionylated proteins, there is consid-
erable overlap or redundancy between the Grx and Trx
systems when recycling disulfides of redox proteins. The
extent of redundancy might depend on the organism [re-
viewed in Garcia-Santamarina et al. (124)]. In Escherichia
coli, the two systems seem largely redundant (at least one of
the two systems is essential). In contrast, in eukaryotes such
as yeast, they are not fully redundant and, actually, it seems
that the GSH/Grx system does not have a significant function
and GSH would only act as a backup for the Trx system.
Despite this more or less significant redundancy, Trxs and
Grxs have distinct substrate specificity, which is controlled
by short- and long-range electrostatic interactions between
oxidoreductases and their substrates as well as by geometric
complementarity. Therefore, the amino acid composition of
areas outside the active site or even outside the contact area is
more important than the composition of the active site that
would only affect the redox potential, not the determinant for
specificity (32). In agreement with this, the surface of indi-
vidual Grxs and Trxs is where they mostly differ.
C. Mammalian redox-regulated proteins
The development of in vivo thiol trapping methodologies
combined with mass spectrometry has produced a growing
body of data supporting the role of oxidative modifications
of protein thiols in the regulation of the function of a diverse
set of proteins involved in diverse physiological and path-
ological responses. Examples in mammals of these cellular
processes include growth factor signaling, hypoxic signal
transduction, autophagy, immune responses, cell prolifera-
tion, and differentiation or metabolic reprogramming, to
name a few. It is not the purpose of this section to provide a
comprehensive list of different types of mammalian redox-
regulated proteins, but, instead, we suggest recent reviews
that provide examples of redox-regulated kinases, phos-
phatases, and transcription factors involved in cancer and
cell proliferation (121), hypoxia (327), inflammatory pro-
cesses (219), blood pressure homeostasis (289), and gly-
cemic control (273), among others.
Many of the redox-regulated proteins fall into the category
of kinases, phosphatases, and transcription factors. However,
there are also other types of proteins whose activity has been
shown to be redox regulated, such as proteins involved in the
cytoskeleton dynamics such as actin, tubulins, cofilin, se-
maphorins (125), GTPases (146, 184), protein quality control
proteins (40, 389), or dehydrogenases such as GAPDH (282).
Despite a large number of identified redox-regulated pro-
teins, the depth of the biochemical characterization of the
signal transduction pathway (actual intra- or extracellular
messenger, type of thiol modification, the potential role of
other Cys in the same protein, transduction mechanism) is,
with a few exceptions, quite low. A detailed biochemical
characterization of the signaling mechanism is not only im-
portant per se, but also to properly design mutant thiol redox
switches and animal knock-in models bearing these muta-
tions into the native genomic loci to analyze the physiological
relevance of a particular redox modification, which in
mammalians is far from being established.
Regarding transcription factors, a number of them are
believed to be redox regulated in vivo by H2O2. From a broad
perspective, transcription factor regulation by H2O2 may
depend on redox regulation of kinases and phosphatases
whose final effector is a transcription factor. In a stricter
sense, redox-regulated transcription factors refer to those
bearing H2O2-sensitive Cys located at the DNA binding
interface, or at the domains of interactions with either
co-activators, co-repressors, or transport machinery. These
transcription factors, on reversible oxidation, would modify
their promoter recognition, recruitment of co-regulators, or
subcellular localization. Many in vitro and cell culture studies
support the identification of Cys residues as thiol switches
in transcription factors, but, as mentioned earlier, studies
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showing the complete biochemical mechanism, or the real
significance of these switches are still missing. We will dis-
cuss here two of the redox-regulated transcription factors that
have been better characterized: Kelch-like ECH-associated
protein-1 (Keap1) and STAT-3.
Keap1/nuclear factor erythroid 2–related factor 2 (Nrf2) is
the Cys-based sensor of oxidative stress, reminiscent of the
well-characterized Yap1 and Pap1 in budding and fission
yeast (80, 363), respectively, that activates the transcription
of antioxidant genes on induction by electrophiles and oxi-
dants. This redox-stress sensing system has been thoroughly
studied regarding its molecular mechanism and physiological
significance (91). Keap1 interacts with the transcription
factor Nrf2 through its degron domain and with Cullin 3 to
form a ubiquitin E3 ligase complex that in basal conditions
ubiquitinates Nrf2, which is then degraded by the protea-
some. Under oxidative or electrophilic stress, including
H2O2, specific Keap1 Cys residues are modified, Keap1-
based E3 ubiquitin ligase activity is inhibited, and, as a
consequence, de novo synthesized Nrf2 is stabilized and ac-
cumulates in the nucleus. Keap1 has at least 10 reactive Cys,
among which Cys-151, Cys-273, and Cys-288 act individu-
ally and/or in cooperation as sensors of various electrophiles.
In particular, the importance of Cys-151 as a sensor has been
verified in transgenic mice expressing Keap1 with Cys-151
substituted with serine. The functional significance of the
other Cys residues in Keap1 has also been examined by using
site-directed mutagenesis. The diversity of response profiles
depending on the inducers and modified Cys has led to the
concept of ‘‘Cys code’’ by which the Keap1–Nrf2 sensor is
unique in that it responds to a diverse array of chemicals and
oxidative insults employing multiple Cys. Based on this code,
Nrf2 inducers have been classified into at least five classes
(306). In the particular case of H2O2, Nrf2 induction is in-
dependent of the three main Keap1 Cys: 151, 273, and 288.
Thus, mouse embryonic fibroblasts established cell lines with
Keap1C151S/C273W/C288E and showed Nrf2 levels similar to
those of a wild-type (WT) cell line on treatment with H2O2
(306). The role of Cys-151 in H2O2 response seems to be
restricted to the formation of an intermolecular bond between
two Keap1 subunits (113), but how this redox switch is
transduced into increased Nrf2 accumulation remains un-
known. Other H2O2-sensitive Cys residues in Keap1 are Cys-
226 and Cys613, which are involved in an intermolecular
bond that is further increased after treatment with H2O2.
Another unresolved question related to Keap1 H2O2 signal-
ing is whether the specific Cys receive oxidant equivalents
directly from H2O2 or through a redox relay.
Signal transducer and activator of transcription 3 (STAT3)
is a transcription factor that responds to cytokines and growth
factors by forming homo- and heterodimers and by nuclear
translocation to the nucleus on phosphorylation by receptor-
associated Janus kinases. In a screen for mixed disulfides
with Prxs, the laboratory of Tobias Dick identified STAT3 as
a mixed disulfide with Prx2 and demonstrated that Prx2
mediated the oxidation and oligomerization of STAT3 by
both H2O2 and interleukins (ILs) (328). They could also
identify that the STAT3 Cys was involved with the Prx2
interaction and suggested two independent pathways that led
to the formation of either STAT3 dimers or tetramers. In both
pathways, there was a concerted disulfide exchange that
started from a Prx2-STAT3 monomer involving the C-
terminal domain of STAT3 containing the trans-activation
domain (AD). Interestingly, the Prx2-driven oxidation of
STAT3 resulted in an inhibition of STAT3-driven tran-
scription rather than activation of the STAT3 function.
STAT3 represents the first example of a mammalian redox-
regulated protein where a redox relay H2O2 transduction
mechanism has been demonstrated.
III. Expression and Regulation of NOXs
in Skeletal Muscle
Although ROS and other highly reactive molecules may be
the result of environmental insults, they are continuously
formed within cells from side reactions of normal metabo-
lism. Under normal physiological conditions, ROS are usu-
ally produced at subtoxic levels, in a regulated way, and
through different mechanisms. The cellular localization of the
NOX family of proteins and the concomitant localized pro-
duction of superoxide (O2
$-)/H2O2 make these particularly
relevant in terms of redox signaling, because transient and
high local concentrations of H2O2 may be required to oxidize
target proteins (see Section II.B). The following sections of
this review will be devoted to a comprehensive revision of the
NOX family biology and what it is known in muscle.
A. A brief history of the NOX family
The NOX family currently comprises seven mammalian
homologs named NOX1 to 5 and DUOX1 and 2 (Fig. 4). For
a detailed account of the differences in their structure/func-
tion, the reader is referred to several excellent reviews on this
subject (27, 198). Here, only a brief account of the NOX2
discovery and of NOX isoforms will be given for reference,
after which we will focus on the structure/function of NOX2
and its potential regulatory mechanisms in skeletal muscle.
Historically, the heme-containing b558 flavocytochrome
was described in 1978 as an integral membrane protein
complex lacking in patients with the rare inherited human
immune disorder chronic granulomatous disease (317), a
condition characterized by an absent respiratory burst in
phagocytes. Later, in 1986–1987, the catalytic gp91phox
subunit of the b558 complex was cloned (304, 351), fol-
lowed by the discovery of the remaining five current NOX2
subunits within the subsequent 7 years. These included the
description of the second b558 integral membrane subunit
p22phox in 1987 (90, 315), then the cytoplasmic subunits
p47phox and p67phox (365), Rac GTPase isoforms (3), and,
lastly, the nonessential modulatory subunit p40phox (379).
Mutations in all of these subunits have now been linked to
chronic granulomatous disease (303). The existence of ad-
ditional nonessential subunits has been suggested but not
firmly established.
Up through the 1990s, six other isoforms of the NOX su-
perfamily of proteins sharing homology with the gp91phox
catalytic subunit were discovered (Fig. 4). Gp91phox cata-
lytic subunit was renamed NOX2 in the novel terminology
and is, therefore, called NOX2 in the remainder of this re-
view. The NOX family shows distinct tissue-selective ex-
pression patterns and functions. Thus, NOX1 is enriched in
the colon epithelium, NOX2 in phagocytes, NOX3 in the
inner ear, NOX4 in kidney epithelial cells, NOX5 in spleen
and testis, and DUOX1 and 2 in the thyroid gland. Based on
similarities in their regulation, the NOX family can be
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divided into three subfamilies: (i) NOX1–3, which requires
p22phox and cytosolic subunits for activation; (ii) NOX4,
which is p22phox- and Poldip2 dependent but active without
cytosolic subunits (366); and (iii) the calcium (Ca2+)-
dependent and p22phox and cytosolic subunit-independent
NOX5 and DUOX1 and DUOX2. NOX1–3 and NOX5 re-
lease O2
-, NOX4 generates both O2
- and H2O2 (350), and
DUOX isoforms generate predominantly H2O2 (153).
B. Expression of NOX isoforms in skeletal muscle
NOX isoform expression has been measured in different
skeletal muscle model systems. For context, all NOX iso-
forms reported in skeletal muscle are included in this section.
In immortalized mouse skeletal muscle C2C12 cell cul-
ture, NOX1, 2, 4, DUOX1, and DUOX2 are detectable at the
messenger RNA (mRNA) level (105). In adult rat whole
muscle lysates, NOX2, NOX4, and DUOX1 mRNA are ex-
pressed, whereas data on the expression of DUOX2 are
conflicting (220, 339). NOX2 and NOX4 exhibit a fiber type-
dependent mRNA expression, higher in slow-twitch oxida-
tive compared with fast-twitch glycolytic muscles (220). At
the protein level, the expression of all NOX2 subunits and
NOX4 has been confirmed by immunoblotting in isolated
mouse single muscle fibers (309). Consistent with the mRNA
expression being higher in slow-twitch muscle, NOX2 pro-
tein expression by Western blotting was visually highest in
adult rat diaphragm, intermediate in soleus, and lowest in the
more glycolytic gastrocnemius muscle (162). Interestingly,
however, the fiber-type dependence in rodents may only
apply to some NOX2 complex regulatory subunits such as
Rac1 (341) but not p22phox and p47phox (162). Whether the
reported differences in subunit expression relate to intrinsic
muscle fiber-type differences or to different fiber-type re-
cruitment patterns (e.g., postural vs. nonpostural muscles)
remains to be seen. DUOX1 mRNA did not differ signifi-
cantly between muscle types (220). To our knowledge,
DUOX1 protein expression has not been confirmed in skel-
etal muscle nor are data available on DUOX2 protein ex-
pression in muscle. In human muscle biopsies, p67phox (265)
and Rac1 (341) protein expression was detected by immu-
noblotting, suggesting conserved expression of NOX2 com-
plex in human muscle, but this requires further investigation.
C. Myocellular localization of NOX isoforms
At the subcellular level, NOX2 in phagocytes is known to
reside in phagosomes, secretory vesicles, specific granules,
and the surface membrane. Upon activation, NOX2 translo-
cates to the plasma membrane via exocytosis to produce O2
$-
extracellularly and inside endocytosed phagosomes (263).
Within the plasma membrane, NOX2 may be localized to
lipid rafts and caveolae (275). A subset of endocytosed sur-
face membranes containing NOX2 termed ‘‘redox-active
endosomes’’ may produce O2
$-/H2O2 at specific subcellular
sites depending on their localization (275). In rat H9c2 car-
diac muscle cells, NOX2 complex subunits p47phox and
p22phox and oxidative stress measured as tyrosine ni-
trosylation increased at the nuclear pore complex in response
to ischemia (131). In skeletal muscle, NOX2 has been reported
FIG. 4. Overview of the
different NADPH isoforms
and their subunits. Al-
though similar in structure
and function, NOX family
members differ in their acti-
vation mechanism. NOX2
activation requires a cytosolic
subunit assembly (p47phox,
p67phox, Rac1, and p40phox)
to interact with the membrane-
bound subunits (gp91phox and
p22phox). NOX1 and 3 ac-
tivity require NOXO1 and
NOXA1, and the small
GTPase Rac. NOX4 is con-
stitutively active but requires
the p22phox subunit. NOX5,
DUOX1, and DUOX2 are
activated by Ca2+ and do not
appear to require subunits. To
see which subunits are ex-
pressed in skeletal muscle,
read Section III in the text.
Ca2+, calcium; NOX, NADPH
oxidase. Color images are
available online.
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at the protein level to be predominantly localized to not only
T-tubules based on immunofluorescence microscopy and
biochemical fractionation studies (144) but also close to or
within the sarcolemma for NOX2, p67phox, p47phox, and
p22phox in transverse cryosections (309). p40phox has been
shown by immunofluorescence microscopy of single mouse
flexor digitorum brevis (FDB) fibers to translocate to the sar-
colemma, whereas no movement of p67phox could be detected
(309). Whether this reflects a bonafide noncanonical move-
ment pattern of some NOX2 regulatory subunits in skeletal
muscle or a limitation of confocal microscopy to resolve
movement in the molecularly packed muscle fiber is currently
unclear. NOX4 was found in the surface membranes and in
mitochondrial fractions (309) colocalizing with ryanodine re-
ceptor 1 (RyR1) in the sarcoplasmic reticulum (SR)-enriched
fractions and by immunofluorescence microscopy (339). The
localization of DUOX1 and 2 proteins has, to our knowledge,
not been studied in skeletal muscle.
D. Molecular regulation of NOX2 activity
and expression in skeletal muscle
As reviewed in detail in later parts of this review, NOX2
expression and/or activity is increased in skeletal muscle by a
number of physiological and pathophysiological stimuli.
Most of what is known about the regulation of NOX2 at the
molecular level is inferred from studies in other cell types, in
particular phagocytes.
As illustrated in Figure 5, an increase in NOX2 activity
requires the integral membrane protein heterodimer complex
of NOX2 and p22phox to recruit a complex containing the
cytosolic regulatory subunits, p47phox, p67phox, p40phox,
and guanosine triphosphate (GTP)-loaded Rac GTPase (198).
In the canonical model, p47phox forms a heterotrimer complex
with p40phox and p67phox in resting cells, whereas inactive
GDP-bound Rac is sequestered away from this complex by its
cytosolic binding-partner Rho GDP-dissociation inhibitor
(RhoGDI). On activation, GTP-bound Rac1 binds p67phox,
and all four cytosolic subunits are recruited to the membrane-
bound NOX2-p22phox heterodimer. In this process, p47phox
is proposed to act as a molecular organizer that on phosphor-
ylation becomes able to bind the cytosolic part of p22phox.
p47phox also binds membrane phospholipids, assisted by the
phospholipid-binding p40phox subunit. By interacting with
p22phox, p47phox brings the NOX2-activating subunit
p67phox in contact with the adjacent NOX2 subunit to activate
the enzyme. Rac1 binding to p67phox further increases the
recruitment of p67phox to the membrane (247) and is also
proposed to cause a conformational change in p67phox that is
necessary for NOX2 activation (285). Cell-free reconstitution
studies have demonstrated that NOX2, p22phox, p47phox,
p67phox, and Rac1 are sufficient for NOX2 activity in vitro
(338); whereas p40phox is considered nonessential for NOX2
activity (379).
Later, the structure and function of the subunits of NOX2
and their role in NOX2 activation are detailed with the em-
phasis on possible skeletal muscle-relevant aspects. The
connectivity between NOX2 subunits is further illustrated in
Figure 6. For excellent reviews on generic NOX2 structure/
function, see Lambeth (198) and Sumimoto (338).
FIG. 5. Proposed mechanisms for NOX2 activation and redox signal propagation. In the unstimulated condition,
NOX2 and p22phox are present in the cell membrane or redox endosomes. On stimulation, p47phox is phosphorylated and
Rac1 is released from RhoGDI and becomes GTP-loaded. This allows the cytosolic subunit assembly to interact with and
activate the membrane-bound NOX2/p22phox dimer. NOX2 generates O2
$-, which is rapidly dismutated to H2O2. This
H2O2 has to reenter the cytosol, possibly via AQPN channels, to modify its target proteins. Outside the cell, H2O2 might, in
addition, act as a paracrine signal. AQPN, aquaporin; GDI, guanosine nucleotide dissociation inhibitor; GTP, guanosine
triphosphate; RhoGDI, Rho GDP-dissociation inhibitor. Color images are available online.
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1. NOX2/gp91phox. NOX2 is the catalytic subunit of
the NOX2 holo-enzymatic complex. It has a predicted mo-
lecular weight of *65 kDa but runs as a broadband around
*91 kDa on a Western blot due to variable N-terminal gly-
cosylation (268, 369). Canonically, the NOX2 subunit gen-
erates O2
$- at the exofacial side of the phospholipid bilayer
membrane by transferring electrons from NADPH on the
cytosolic side via FAD and then via two stacked hemes to
extracellular molecular oxygen. Structurally, the enzyme can
be divided into two parts of roughly the same size, a C-
terminal cytoplasmic domain containing NADPH and FAD-
binding sites and the N-terminal membrane domain with six
a-helical transmembrane parts and two distinct heme groups
coordinated by four histidine residues in helix 3 and 5.
NOX2 complex activity is proposed to be regulated by
protein–protein interaction with the integral membrane
p22phox and the cytosolic regulatory subunits p47phox,
p67phox, and Rac (Fig. 6). Phosphorylation by protein ki-
nase C (PKC) isoform at undetermined sites in the C-
terminal domain was reported to increase electron flow ac-
tivity and binding to p47phox, p67phox, and Rac2 in human
neutrophils (291). More recently, Ser486 in the so-called
NOX-specific insertion sequence in the C-terminal NADPH-
binding region was suggested to be an inhibitory phosphor-
ylation site targeted by ataxia telangiectasia mutated kinase
(ATM) (26). Since the NOX2 complex activates ATM (26,
387), this might constitute a negative feedback loop to ter-
minate the NOX2 activity. Interestingly, both ATM and PKC
are expressed in skeletal muscle. In mouse muscle, ATM is
much higher in fast-twitch extensor digitorum longus (EDL)
muscle compared with slow-twitch soleus muscle, and
knockout (KO) of ATM reduces insulin-stimulated glucose
uptake and impairs insulin and IGF1 signaling at different
steps (59). Similarly, PKC isoforms have been ascribed both
positive and negative functions in skeletal muscle glucose
metabolic regulation by insulin and exercise/contraction
(313, 343). In isolated mouse skeletal muscle fibers, NOX2-
dependent H2O2 production during electrically stimulated
contraction was proposed to require PKC activation down-
stream of autocrine ATP-activating purinergic receptors
(P2Y1) signals by using pharmacological inhibitors (85).
Whether this pathway regulates NOX2-dependent O2
$-/
H2O2 production in vivo deserves further investigation.
It is worth noting that NOX2 activity is fairly specific to
NADPH, and this enzyme works poorly with NADH as the
electron donor (198). Seemingly in conflict with this view, a
study in isolated rat diaphragm, and soleus and gastrocne-
mius muscles observed an approximately three- to six-fold
higher extracellular H2O2 production by using the same
molar concentration of exogenous NADH compared with
NADPH when measured using Lucigenin-derived chemilu-
minescence (162). However, it should be noted that the
230lM lucigenin concentration used in the study by
Janiszewski et al. probably resulted in so-called ‘‘redox cy-
cling’’ and overestimation of particularly NADH-driven
oxidase activity (161). Case in point, this overestimation
artifact—increasingly observable above *50lM lucigenin
concentrations—is shared by other cell types and is not un-
ique to muscle (161, 209). Thus, we do not find compelling
evidence to support the notion that skeletal muscle NOX2 has
a unique preference for NADH over NADPH. This should be
verified by other methods.
FIG. 6. Overview of molecular interactions between the NOX2 subunits. Domain structure and interaction sites
between p47phox, p67phox, p40phox, and Rac1 with NOX2-p22phox under (A) unstimulated and (B) stimulated condi-
tions. See the main text for explanation. AIR, autoinhibitory; PB1, Phox and Bem 1; PRR, proline-rich region; PX,
phagocyte oxidase. Color images are available online.
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2. p22phox. p22phox is a shared constitutive binding
partner of NOX1–4 (156). p22phox also co-immunoprecipitates
with DUOX, although no functional role of this interaction
has been established (370). p22phox is not glycosylated and
runs around the predicted *22 kDa on a Western blot (90).
p22phox is most likely a dual membrane-spanning protein
with the N and C-terminals facing the cytoplasm (158). It has
been ascribed the dual function of stabilizing the NOX2
subunit expression and acting as a linker to the cytoplasmic
regulatory protein p47phox (81). In the absence of either
p22phox or NOX2 subunit, the monomers are degraded by
proteasomal degradation (81, 274). Similar to NOX2 protein,
p22phox has long been known to be stimulation dependently
phosphorylated (294). Site-directed mutagenesis studies of
Thr147 near the C-terminal poly-proline helix and adjacent
alpha helix region (residues 151–160) of p22phox critical for
p47phox binding (204, 264) were shown to reduce O2
$-
production in CHO cells by >75% by blocking p22 binding to
p47phox (205). Importantly, the reduction in activity oc-
curred without effects on NOX2 subunit expression (205).
PKC isoforms a and d were able to phosphorylate this site
in vitro but whether PKC is the bonafide kinase acting on this
site in vivo remains uncertain.
3. p47phox. p47phox is a nonglycosylated protein run-
ning around the predicted *47 kDa on a Western blot. As
is illustrated in Figure 6A, p47phox contains an N-terminal
lipid-binding phagocyte oxidase (PX) domain, tandem SH3
domains, an autoinhibitory domain, and a C-terminal proline-
rich region (PRR) (27). In the canonical model for NOX2
activation, this protein plays a critical role in the recruitment
of cytosolic subunits to the membrane-inserted NOX2/
p22phox heterodimer. p47phox is necessary for the activa-
tion of NOX2 in vivo, but its requirement can be overcome by
high amounts of p67phox and Rac under cell-free conditions,
supporting that it is an NOX2-organizing rather than an
NOX2-activating protein (114, 192).
During NOX2 activation, p47phox becomes heavily
phosphorylated on 10 sites between residues 303–379 in the
C-terminal end (96, 316); for review see El-Benna et al. (98).
Only the most phosphorylated form of p47phox translocates
to the membrane (261). Phosphorylation of p47phox is pro-
posed to relieve autoinhibition to allow the tandem SH3
domains to sandwich the PRR of p22phox (324). Early mu-
tational analyses studies found that mutation of all 10 sites
rendered p47phox incapable of activating NOX2 and sug-
gested that Ser379 was most critical to NOX2 activation
(104). However, the proposed role of Ser379 phosphorylation
was challenged by later studies showing that Ser379 phos-
phorylation destabilized the interaction with p67phox and
negatively regulated NOX2 activity (377). Rather, phos-
phorylation of Ser303, Ser304, and Ser328 was sufficient to
relieve autoinhibition and allow p47phox to interact with
p22phox (9). The conformational change elicited by phos-
phorylation of p47phox also allows the N-terminal PX do-
main to bind membrane phospho-inositides, presumably
PtsIns (3, 4) P2, although the affinity and specificity of this
interaction was reportedly low (174). It is worth noting that
this region may also interact with phosphatidic acid (10),
phosphatidylserine (333), and the actin cytoskeleton via
Moesin (395). This may explain why p47phox can translo-
cate independently of PtsIns (3, 4) P2 (8). p67phox binds with
high affinity to the C-terminal PRR and two alpha-helixes in
the tail-segment of p47phox (173).
Phorbol 12-myristate 13-acetate induces p47phox phos-
phorylation and is a classical activator of various PKC iso-
forms, and phosphorylation of particularly Ser303/304 and
Ser328 has been ascribed to PKC isoforms (9, 74). Other
kinases have also been suggested to phosphorylate p47phox
in various cell types, including Src (61), extracellular signal-
regulated protein kinase (ERK)1/2 and p38 mitogen-
activated protein kinase (MAPK) (97), p21-activated kinases
(PAK) (230), protein kinase B (Akt) (58), protein kinase A
(28), and casein kinase II (271); whereas AMP-activated
protein kinase (AMPK) was proposed to indirectly reduce
p47phox phosphorylation via inhibition of PKC (329). A
similar AMPK-induced inhibition of high glucose-induced
NOX2 activity was observed in cultured adult rat cardio-
myocytes exposed to GLP-1 (24). Lastly, arachidonic acid
may potentiate phosphorylation-induced binding of p47phox
to p22phox (324). All of the kinases and phospholipases
mentioned earlier are present and activated in skeletal muscle
by conditions such as exercise/contraction, adrenergic stim-
ulation, insulin stimulation, and/or different forms of muscle
disease (149, 343). To our knowledge, studies have yet to
investigate the stimulus-dependent phosphorylation of
p47phox in skeletal muscle. Teasing out which kinases target
which sites with different stimuli in skeletal muscle will be a
major challenge for the future.
4. p67phox. p67phox is a 526 amino acid non-
glycosylated protein migrating around 67 kDa on a Western
blot (predicted weight is*60 kDa). From N- to C-terminus,
this protein contains four tetratricopeptide repeat (TPR): an
AD, a Phox and Bem 1 (PB1) domain, flanked by two SH3
domains in the C-terminal half (27, 338). In the resting cell,
p67 binds p40phox via the PB1 domain and p47phox at the C-
terminal SH3 domain in the cytosol (Fig. 6B). On stimulation
and recruitment of the cytosolic heterotrimer to the mem-
brane NOX2/p22phox complex, p67phox additionally binds
GTP-loaded Rac via its N-terminal TPR-containing domain
(Fig. 6B). The general model is that p67phox is thereby put
into contact with the NOX2 subunit via a direct protein–
protein interaction (64, 260).
Not surprisingly, p67phox has also been reported to be
phosphorylated on multiple sites on NOX2 complex stim-
ulation via PKC (29, 112), p38 MAPK and ERK2 (75),
an unidentified tyrosine kinase, MEK1/2, and phosphatase
1/2a-dependent mechanisms (76) although at a much lower
magnitude and stoichiometry than p47phox (112). This phos-
phorylation occurs in the cytosol independent of p47phox
(111). The functions of these phosphorylations have not been
elucidated. In addition to phosphorylation, the stimulation-
dependent binding of GTP-loaded Rac to p67phox is also re-
quired for NOX2 complex activation (Fig. 6).
5. Rac GTPases. Rac is a member of the Ras-like Rho
family of small GTPases, best known for their canonical role
in the regulation of the actin cytoskeleton (299). There are
three highly homologous 192 amino acids and*21 kDa Rac
isoforms, all of which can activate NOX2 (200, 248). Rac1 is
ubiquitously expressed, including in skeletal muscle; Rac2 is
restricted to hematopoietic cells; and Rac3 is mainly ex-
pressed in the central nervous system (147, 251). Key
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features of Rac GTPase is an N-terminal domain that binds
GDP and GTP and contains the two effector-interacting
switch regions, a middle insert domain specific to Rho but not
to other Ras family GTPases, and a C-terminal polybasic tail
containing a geranyl-geranyl lipid anchor (36). Activation of
Rac GTPases occurs via a complicated series of molecular
events. In the resting cell, Rac1 is sequestered by its molec-
ular chaperone protein RhoGDI in the cytosol, covering the
prenylated C-terminus of Rac1. GTP loading of Rac1 requires
the release of Rac1 from RhoGDI, allowing the C-terminus of
Rac1 to interact via electrostatic and lipophilic attraction with
the negatively charged inner leaflet of the plasma membrane
lipid bilayer. In a poorly understood sequence of events, Rac1
GTP loading presumably occurs somewhere in transit to the
cell membrane, catalyzed by guanine nucleotide exchange
factors (GEFs) and GTPase activating proteins. The GTP
loading of Rac GTPases acts as a binary on/off switch, al-
lowing the N-terminal switch domain to interact with and
modulate downstream effectors. In addition, phosphorylation
by Akt on Rac1 Ser71 adjacent to switch II modulates the
interaction between Rac1 and some substrates, including
SRA-1, WASP, and PAK but not others (197, 396).
In relation to NOX2 activation, GTP-loaded Rac GTPases
bind p67phox (87). Mutational analyses showed that this
interaction required a functional N-terminal switch I region
of Rac and a second region, residues 143–175, near the C-
terminus for maximal binding (88). Rac1 binds p67phox in
the N-terminal TPR repeat region (190). The ability to bind
p67phox and activate NOX2 is a unique feature of Rac
GTPases that cannot be performed by closely related Rho
GTPases such as Cdc42, which lacks the critical residues for
p67phox interaction. Rac has also been proposed to bind
NOX2 subunit via its insert region (86), but this is contro-
versial (285). Detailed analyses of a chimeric construct be-
tween Rac1 and p67phox revealed that Rac GTPases function
to recruit p67phox to membranes but additionally may cause
a conformational change in p67phox that is critical to its
activation of the NOX2 subunit.
In skeletal muscle, Rac1 GTP loading and/or autopho-
sphorylation of PAK1/2 Thr423 as a surrogate marker of
Rac1 activation are increased by in vivo and ex vivo exercise/
contraction, insulin, and ex vivo passive stretching in various
experimental models in rodents and human skeletal muscle
(340, 341, 355, 398).
As reviewed elsewhere (60), although a handful of GEFs
have been linked to Rac1 activation in muscle cell culture
with different stimuli, these have not been confirmed in adult
skeletal muscle. No GTPase-activating proteins for Rac1
have been identified in skeletal muscle, and the role of
RhoGDI in skeletal muscle has also not been investigated.
Whether Ser71 phosphorylation of Rac1 modulates p67phox
interaction has, to our knowledge, not been investigated (see
Fig. 5 for subunits comparison and putative interactions).
Rac1 binds other effector proteins, including PAK and
WASP, to regulate the actin cytoskeleton. As already men-
tioned, p47phox may be phosphorylated by PAK (230), and
p47phox may interact with the actin cytoskeleton via moesin
(380, 395), suggesting additional ways in which Rac acti-
vation might regulate NOX2 activity.
AMPK is a kinase activated in skeletal muscle by ATP-
turnover during exercise/contraction, prolonged starvation,
and pharmacological activators. Its classically ascribed func-
tion is to restore energy homeostasis by inhibiting anabolic
signaling pathways and stimulating catabolic signaling path-
ways (187). As discussed in a previous section (see Section
III.D.3), AMPK activation has been proposed to impair
NOX2 activity. In skeletal muscle, AMPK activation by DNP
also inhibits Rac GTP loading in L6 rat muscle cell culture
(341). If reflective of the Rac1 pool regulating NOX2, this
indicates that AMPK might reduce Rac1-dependent NOX2
activation in muscle. Another mechanism for AMPK inhibi-
tion of NOX2 activity might be speculated to involve inhi-
bition of nucleoside diphosphate kinase (NDPK) by AMPK-
dependent phosphorylation of Ser120 (267). NDPK catalyzes
the ATP-dependent replenishment of GTP by using GDP as a
substrate, and this has been suggested to regulate NOX2 ac-
tivation (249, 285). Whether AMPK-dependent inhibition of
Rac1 GTP loading occurs via NDPK deserves further study.
6. p40phox. This nonessential component of NOX2 is a
339 amino acid *40 kDa protein containing from N- to C-
terminus a PX, SH3, and PB1 domain. It physically and
stably binds p67phox and has been shown to enhance the
recruitment of p67phox and p47phox to membranes (196).
This enhanced recruitment is likely mediated by the N-
terminal PX domain, which strongly binds phosphatidylino-
sitol 3-phosphate (PI3P) (10, 174). The SH3 domain may, in
addition, interact with p47phox (159, 231). A number of
phosphorylation sites have been reported in p40phox, among
which Thr154 and Ser315 are likely PKC sites that increase
during NOX2 activation (42). The function of Thr154 is
likely to decrease NOX2 activity (218).
Phosphorylation of phosphatidylinositol (PI) to generate
PI3P is catalyzed by the class III phosphatidylinositol 3 kinase
(PI3K; VPS34), an enzyme generally linked to membrane and
vesicle trafficking events, including endocytic trafficking,
phagocytosis, cytokinesis, and autophagy (22). VPS34 is
present in skeletal muscle and is activated by acute resistance
exercise in humans (222). VPS34 has been shown to exist in
multiple complexes with distinct subunit composition, some
of which regulate autophagy whereas others have been linked
to general protein trafficking (183). Whole-body heterozy-
gous kinase-dead VPS34 knock-in mice have increased in-
sulin sensitivity, hyperactivated AMPK explained by lowered
mitochondrial respiration (35). Whether modulation of
NOX2 activity contributes to this phenotype is unclear.
E. The fate of generated O2
$-
O2
$- generated by skeletal muscle NOX2 is released
extracellularly by NOX2 inserted into the sarcolemma or
T-tubules (269). To be able to act as a second messenger
within the cytosol, the O2
$- generated by NOX2 must first
reenter the muscle fiber. O2
$- in solution rapidly and spon-
taneously dismutates to H2O2 at a rate of 10
5 M/s, and ex-
tracellular superoxide dismutase (SOD) 3 can increase this
rate to 109 M/s (393). In contrast to O2
$-, H2O2 is relatively
stable in solution and is, therefore, often proposed as the more
likely signaling molecule. It should be noted, however, that
there is also evidence supporting a transmembrane signaling
role for O2
$- independent of conversion to H2O2 (110). H2O2
was long believed to cross the plasma membrane merely by
passive diffusion. However, O2
$- entry into cells is now
known to occur via chloride channel 3 (ClC3) (110, 137).
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Similarly, AQPN isoforms 3, 8, 9, and 11 have been shown to
facilitate H2O2 entry whereas AQPN1 and 4 have little to no
H2O2 transport capacity (135, 235, 246). Skeletal muscle
expresses multiple chloride channel isoforms including ClC3
(164) and AQPN isoforms 3,4,5, and likely 9 but not 11 (115,
368). There is evidence to suggest that these proteins are
themselves regulated by post-translational modifications and
subcellular trafficking (94, 206), adding further complexity to
their potential role as H2O2 transporters.
NOX2 may also signal after endocytosis in ‘‘redox-active
endosomes’’ (266, 331). In these organelles, O2
$- is produced
in the membrane-enclosed lumen (analogous to phagolyso-
somes) and must exit this compartment to initiate signal
transduction cascades (Fig. 5). This presumably occurs by the
same mechanisms as described earlier for the plasma mem-
brane. Of note, redox-active endosomes appear to recruit SOD
to their cytosolic surface to rapidly dismutate O2
$- to H2O2
when exiting the organelle (258, 331). From thereon, the H2O2
signal may be then transduced via reversible Cys-oxidation as
discussed in Section I.
In summary, ClC3 and muscle-relevant AQPN isoforms may
contribute to the signal transduction by NOX2 by enabling O2
$-
and assisting H2O2 in movement across cellular membranes to
initiate intracellular signaling. However, the requirement of
these proteins needs to be confirmed experimentally in skeletal
muscle. Further, both ClC3 and AQPNs have been shown to
undergo stimulus-dependent protein trafficking (65, 226) and
post-translational modifications (170), which may also modu-
late NOX2 signaling.
IV. NOX2 Signaling in Exercising Skeletal Muscle
A. Brief introduction to ROS signaling in the context of
physical exercise
Exercise training improves the function of many organs in
the human body, reducing the risk of developing diseases such
as obesity, cancer, type II diabetes, and mental disorders (279).
Skeletal muscle is highly responsive to both acute exercise and
exercise training. Literally, thousands of post-translational in-
tracellular signaling events are altered by a single bout of ex-
ercise in human skeletal muscle (149), acutely controlling, for
example, metabolism, autophagy, protein trafficking, mRNA
transcription, and protein translation (Fig. 7). The integration of
molecular signaling from successive acute exercise bouts is
FIG. 7. Redox signaling may contribute to adaptations to different forms of exercise training. Long-term adaptations
to exercise training, such as increased muscle mass with resistance exercise and endurance capacity with endurance
exercise, are mediated by distinct acute signaling events and downstream changes in transcription and translation. The
AMPK and mTORC1 pathways are presented in the simplified diagram as classical examples of endurance and resistance-
exercise-activated pathways, respectively. Redox signaling may act in parallel and/or crosstalk with these and other signals
transduction pathways to modulate exercise training response. AMPK, AMP-activated protein kinase; mTORC1, mam-
malian target of rapamycin complex 1; NAD, nicotinamide adenine dinucleotide; NF-jB, nuclear factor-jB; Nrf2, nuclear
factor erythroid 2–related factor; PA, phosphatidic acid; SIRT, NAD-dependent deacetylase sirtuin. Color images are
available online.
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further translated into chronic phenotypic changes produced by
long-term training (283). Acute and chronic effects of exercise
include enhanced skeletal muscle insulin sensitivity, mito-
chondrial biogenesis, and improved antioxidant defense (138).
As is illustrated in Figure 7, several ‘‘exercise signals’’ have
been proposed to relay these beneficial adaptations, including
redox signals (286).
The first evidence suggesting increments in oxidants dur-
ing exercise was obtained by measuring increased lipid per-
oxidation byproducts in expired air from exercising human
subjects (89). Later, Davies et al. demonstrated an increase in
free radicals elicited by treadmill running in rats by using
electron spin resonance spectroscopy in muscle lysates (77).
Currently, it is widely accepted that exercising muscle fibers
may produce ROS from several sources, and the primary
source of ROS has been a topic of controversy during the past
decade (287). This controversy may, in part, relate to the
technical challenge of measuring O2
$-/H2O2 generation
during in vivo exercise (160). This section will first briefly
discuss studies investigating the role of different ROS in
skeletal muscle exercise adaptations in general, and then
focus on presenting the emerging evidence establishing
NOX2 as a major source of ROS during physiological exer-
cise conditions and linking NOX2 to both acute and chronic
exercise adaptations.
B. NOX2 as a primary ROS source during exercise
in vitro and in vivo
Since oxygen consumption is increased during exercise,
several authors have assumed that ROS production during
exercise is a byproduct of the elevated oxygen consumption
by mitochondria to meet the increased myocellular energy
demand (175, 177, 191). Early reports estimated O2
$- pro-
duction to account for 1%–2% of consumed oxygen by iso-
lated mitochondria under particular experimental conditions
(43). However, more recent studies with improved tech-
niques showed that only *0.12%–0.15% of mitochondrial
respiration is converted to H2O2 (194, 332, 349). Further, it
was demonstrated that in vitro, electrical stimulation does not
increase mitochondrial redox-sensitive GFP (roGFP) (244) or
Mitosox oxidation in skeletal muscle fibers (309). We have
recently found support for these observations during physi-
ological exercise conditions by showing that oxidation of the
mitochondrial matrix-targeted Orp1-roGFP is decreased, ra-
ther than increased, by moderate-intensity treadmill exercise
in mouse skeletal muscle (141). There are several potential
explanations for an exercise-stimulated drop in net mito-
chondrial H2O2. Overall, the net mitochondrial H2O2 pro-
duction depends on the capacity for generation and removal
of H2O2 (259). The production of H2O2 by mouse mito-
chondria is markedly decreased in the presence of high levels
of ADP (259), which increases during exercise. Further, it has
been shown that H2O2 consumption by rat skeletal muscle
mitochondria is higher at lower pH (25), suggesting that in-
tracellular acidification during muscle contraction shifts mi-
tochondria toward a more antioxidant rather than pro-oxidant
state. Together, available evidence suggests that mitochon-
dria are not a significant contributor of oxidant generation
during exercise.
In contrast to mitochondria, several cell-based studies in the
past decade support the role of NOX2 in muscle contraction-
induced O2
$-/H2O2 generation. In primary rat myotubes, O2
$-
generation (276) and dichlorodihydrofluorescein diacetate
(DCFH) oxidation (102) were first shown to be completely
blocked by nonspecific NOX2 inhibitors diphenyleneiodo-
nium (DPI) and apocynin (APO). These results, indicating
that NOX2 is critical to contraction-stimulated ROS produc-
tion in vitro, have since found increasing support by other
studies in mouse primary myotubes and cultured FDB fibers
using the more specific NOX2 inhibitor gp91ds-tat and ge-
netic deletion of NOX2 complex subunits (Table 1).
Table 1. Studies Addressing the Contribution of NOX2 in Contraction/Exercise Redox Signaling
Muscle model Stimulation model Inhibition approach Inhibition effect Reference
Primary rat myotubes. Field ES DPI Y Cytochrome c. reduction. (276)
Primary rat myotubes. Field ES APO Y CM-H2DCFA oxidation (102)
Single mouse FDB fibers Field ES DPI Y CM-H2DCFA oxidation (244)
Single mouse FDB fibers Field ES DPI
APO
gp91ds-tat
Y DHE oxidation (309)








Single mouse FDB fibers Field ES NOX2 KO mice. Y Oxidation CM-H2DCFDA (211)
Single mouse FDB fibers Field ES gp91ds-tat Y CM-H2DCFA oxidation (85)
Primary mouse myotubes Field ES APO
gp91ds-tat
Y CM-H2DCFA oxidation (139)
Single mouse FDB fibers Field ES gp91ds-tat
Rac1 mKO
Y p47-roGFP oxidation (141)








In vivo mouse TA muscle In vivo high-intensity
interval training
Ncf1* mice Y p47-roGFP oxidation (142)
APO, apocynin; CM-H2DCFDA, 5-(and-6) chloromethyl-2,7-dichloro dihydrofluorescein diacetate; DHE, dihydroethidium; DPI,
diphenyleneiodonium; ES, electrical stimulation; FDB, flexor digitorum brevis; KO, knockout; NADPH, nicotinamide adenine dinucleotide
phosphate; NOX, NADPH oxidase; Rac1 mKO, inducible muscle-specific Rac1 KO; roGFP, redox-sensitive GFP; TA, tibialis anterior.
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Addressing the question of whether in vivo exercise in-
creases NOX2 activity has been technically challenging. The
first study indicating skeletal muscle NOX2 activation during
endurance exercise was published in 2016 (140). One hour
of swimming exercise increased the interaction between
p47phox and the NOX2 subunit in mouse skeletal muscle and
prevented by APO (140). Using the p47roGFP biosensor
developed by Rodney’s group (269), together with a redox
histology technique in mice (116), we have provided in vivo
evidence showing that moderate- (141) and high-intensity
interval treadmill exercise (142) increased NOX2 activity in
mouse skeletal muscle. Importantly, the oxidation of the
cytosol-targeted Orp1-roGFP biosensor was observed in WT
but not in ncf1* mice, suggesting that the NOX2 complex
makes a substantial contribution to cytosolic O2
$-/H2O2
generation during exercise.
DCFH oxidation induced by moderate-intensity exercise in
human and rodent muscle measured in cryosections postmor-
tem is completely absent in mice lacking either p47phox
(ncf1* mouse) or Rac1 (141). This suggests that DCFH oxi-
dation measures NOX2-dependent ROS production in mouse
muscle and that exercise-stimulated NOX2 activation is likely
conversed in humans (141). Together, these studies support a
model where cytosolic O2
$-/H2O2 production in myofibers
during physiological requires an intact NOX2 complex.
C. NOX2 and exercise-stimulated myokines
In 1961, Goldstein suggested the possibility that muscle
contraction stimulates the release of ‘‘factors’’ from muscles
that communicate with other organs (127). Later, skeletal
muscle was, indeed, discovered to be an endocrine organ re-
leasing peptides dubbed myokines (272, 278), metabolites, and,
more recently, small vesicles in response to exercise (378).
Interleukin 6 (IL-6) was the first identified myokine, and it
is produced and released by skeletal muscle in response to
diverse exercise modalities (278). The molecular mechanisms
involved in IL-6 expression and release by skeletal muscle
are still incompletely described. ROS have been shown to be
sufficient to induce the expression of IL-6 in skeletal muscle
cells (139, 193, 221). Interestingly, antioxidant supplemen-
tation was reported to lower the exercise-stimulated IL-6
expression in human subjects (109, 358, 390), suggesting that
redox signaling regulates exercise-mediated IL-6 expression
in muscle.
With regard to NOX2, Henrı´quez-Olguı´n et al. (140)
demonstrated that IL-6 plasma levels were significantly
lower in APO-treated versus saline-treated mice after 1 h of
swimming exercise. This was accompanied by a reduction in
IL-6 mRNA levels in muscle 2 h after in vivo exercise by both
NOX2 and nuclear factor-jB (NF-jB) inhibitors. This sug-
gests that NOX2 regulates exercise-stimulated IL-6 expres-
sion in skeletal muscle, possibly via NF-jB signaling
(Fig. 8), which could be related to IL-6-mediated exercise
benefits recently published in humans (199, 372). Studies
testing the role of NOX2 directly in IL-6-mediated benefits
after exercise training are highly required.
D. NOX2 as a regulator of acute exercise metabolism
in muscle
Muscle contraction increases the demand for energy sub-
strate metabolism and is well known to rapidly increase
skeletal muscle glucose uptake by an insulin-independent
mechanism (298). Key steps determining muscle glucose
uptake during exercise are glucose delivery, glucose trans-
port, and intracellular glucose metabolism (343).
Exercise-stimulated glucose transport requires the translo-
cation of glucose transporter 4 (GLUT4) to the plasma mem-
brane and transverse tubular system (202, 399). Among these,
the muscle contraction-stimulated glucose transport across the
plasma membrane of myofibers has been studied in great detail
and is known to require the translocation of GLUT4 to the
sarcolemma and transverse tubular system (343).
The first study linking ROS to glucose transport stimulation
was by Cartee & Holloszy (1990), who observed that exoge-
nous H2O2 (3 mM) could increase glucose transport into
incubated rat epitrochlearis muscles (56). Later, an inverted
U-shaped dose–response relationship between H2O2 stimula-
tion and glucose transport was reported in murine EDL mus-
cles (145), suggesting that low concentrations of H2O2
stimulated muscle glucose transport whereas high H2O2 in-
duced oxidative damage.
FIG. 8. Molecular responses to
exercise-stimulated NOX2 acti-
vation in skeletal muscle. The
depolarization and/or mechanical
stress elicited by exercise activates
NOX2 and redox activation of
redox-sensitive transcriptions fac-
tors such as NF-jB. This upregu-
lates mRNA expression and release
of myokines such as IL-6. Other
exercise-responsive genes such as
SOD2 and TFAM have also been
shown to be NOX2 dependent (see
Section IV for details). IL-6, inter-
leukin 6; mRNA, messenger RNA;
TFAM, mitochondrial transcription
factor A. Color images are avail-
able online.
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In terms of necessity, glucose transport elicited by ex vivo
contraction and passive stretch was partially blocked by
preincubation with ROS scavengers (57, 242, 310), sug-
gesting that ROS are required for the glucose transport
response by these stimuli. Nevertheless, the infusion of
N–acetylcysteine (NAC) in rats or humans did not affect
in situ contraction- or exercise-mediated glucose transport in
skeletal muscle (240, 243). Recently, Christiansen et al. dem-
onstrated that intravenous NAC infusion attenuated exercise-
stimulated glucose uptake in humans after blood flow restricted
training in human volunteers (62). Methodological differences
might explain these divergent results regarding the necessity of
ROS for glucose transport in muscle, including the use of
distinct exercise modalities, training state, and supplementation
protocols.
During the past decade, the molecular mechanisms
linking exercise-stimulated ROS generation and glucose
metabolism have been a topic of research. The small
GTPase and NOX2 complex subunit Rac1, previously
linked to insulin-stimulated GLUT4 translocation via re-
modeling of the actin cytoskeleton, has emerged as a reg-
ulator of glucose transport by diverse stimulus in
muscle cells (60) and mature skeletal muscle (345). Thus,
both pharmacological inhibition of Rac1 and the actin-
depolymerizing agent latrunculin B blunted passive
stretch- and contraction-stimulated glucose transport in
mouse soleus and EDL muscles ex vivo. Besides, incubated
muscles from inducible muscle-specific Rac1 KO (Rac1
mKO) mice had impaired glucose transport responses to
passive stretch (346) and contraction ex vivo (341). Strik-
ingly, Rac1 mice seemed even more critical for the in-
creases in glucose uptake and GLUT4 translocation in WT
versus Rac1 mKO mice during physiological treadmill
exercise in vivo (347, 348).
In parallel to the proposed actin-dependent mechanisms
(60) for how Rac1 regulates exercise-stimulated glucose
uptake, an NOX2-dependent mechanism has been recently
proposed. The oxidation of p47roGFP and DCFH in-
duced by exercise was shown to be absent in Rac1 mKO
muscles (141). Interestingly, Rac1 and ncf1* mouse mus-
cles presented striking phenotypic similarities, including
greatly reduced muscle exercise-stimulated glucose uptake
and GLUT4 translocation (141). The resemblance between
these models suggests that Rac1 regulates exercise-
stimulated GLUT4 translocation and glucose uptake via
NOX2 (Fig. 9). The downstream mechanisms are unclear at
present and may or may not involve modulation of the actin-
cytoskeleton upstream, downstream, or in parallel to NOX2
activation.
In summary, NOX2 activity is required to increase GLUT4
translocation and glucose uptake under physiological exer-
cise conditions in mice (Fig. 9). The exact mechanism(s)
downstream of NOX2 that control exercise-stimulated
GLUT4 translocation require further investigation.
E. NOX2 and exercise training adaptations in skeletal
muscle
Exercise training is characterized by repeated transient ex-
posures to metabolic, mechanical, and hypoxic stress, among
others (277). These signals are translated into stress-protective
adaptive responses, a concept referred to as exercise hormesis
(300). The redox-signaling version of this paradigm is redox
hormesis, where low-level exposure to ROS elicits beneficial
stress adaptation, whereas too high ROS production relative to
the antioxidant capacity promotes oxidative stress and cyto-
toxicity (Fig. 10). In the context of skeletal muscle, the hor-
metic response to nonharmful levels of oxidants during
exercise has been proposed to contribute over time to the
exercise-training response (Fig. 11). This hypothesis regarding
the requirement of ROS for some training responses has mainly
been investigated by providing general ROS scavengers/anti-
oxidants during acute and long-term training periods [for re-
view see Merry and Ristow (241)]. However, more recent
studies have focused on identifying the specific ROS source(s)
involved in these adaptations. The evidence for the involve-
ment of first ROS, in general, and then NOX2, specifically, in
some of the classical skeletal muscle training adaptations, in-
cluding mitochondrial biogenesis, antioxidant defense, and
increased insulin sensitivity, is reviewed later.
1. Training-induced mitochondrial biogenesis. Increases
in mitochondrial content, function, and turnover in skeletal
muscle are among the most well-described effects of endur-
ance training on skeletal muscle (357). Muscle mitochondrial
content is a product of synthesis (biogenesis) and degradation
(mitophagy) (151). Apart from mitochondrial content, endur-
ance exercise training is also known to influence mitochondrial
morphology, by inducing an elongated mitochondrial network
and decreasing mitochondrial fragmentation in trained mus-
cles of rodents and humans (21, 133)
FIG. 9. Exercise-stimulated glucose
uptake and GLUT4 translocation are
controlled by NOX2. Exercise increases
cytosolic ROS generation by NOX2 pro-
moting GLUT4 translocation to the plasma
membrane and increases muscle glucose
uptake. GLUT4, glucose transporter 4;
ROS, reactive oxygen species. Color ima-
ges are available online.
NOX2 IN SKELETAL MUSCLE 1385
PCG-1a is a well-established regulator of mitochondrial
biogenesis (44, 134) and mitophagy (132) in response to
endurance training. Interestingly, administration of ROS
scavengers reduced the expression of PCG-1a in response to
endurance training in rat (128, 360), mouse (236, 335), and
human muscle (301). Pharmacological inhibition of NOX2
decreased the exercise-stimulated mitochondrial gene ex-
pression (140). Recently, Baghersad et al. demonstrated that
the increase of PCG-1a expression was blunted in NOX2
activity-deficient ncf1* compared with WT muscle in re-
sponse to high-intensity interval training (23). Consistent
with these observations, the high-intensity interval training-
mediated increments of mitochondrial protein content and,
in particular, changes in mitochondrial network morphology
were markedly attenuated in ncf1* compared with WT muscle
(142). Importantly, some exercise-responsive proteins such as
FIG. 11. Repeated exposure to exercise-stimulated ROS production promotes muscle exercise-training adaptation.
Schematic representation of how repeated transient increases of ROS production elicited by each bout of exercise drive the
increased expression of redox-sensitive gene expression (see the text for details), contributing to long-term training ad-
aptation. Color images are available online.
FIG. 10. Redox hormetic regulation of muscle function. Physiological changes in ROS generation induce antioxidant
gene expression to maintain redox homeostasis and other myocellular adaptation to improve overall muscle function. Too
low levels of ROS weaken these responses, whereas too high exposure to ROS overwhelms the antioxidant defense to
promote cytotoxic oxidative stress. Color images are available online.
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GLUT4 responded similarly to exercise training in both WT
and ncf1* mice, suggesting that NOX2 regulates a specific
subset of training adaptations (142). Also worth noting,
pharmacological inhibition of other myocellular ROS sources
seemingly had no effect on training-related mitochondrial
markers in mice (364, 367) and humans (323).
Taken together, this suggests that NOX2-derived O2
$-/
H2O2 production is required for a specific subset of exercise
training adaptation in skeletal muscles related to mitochondrial
content and morphology. Whether this requirement is specific
to short-term HIIT training needs further investigation.
2. Training-induced changes in ROS production capacity
and antioxidant defense. Gene expression of antioxidant
defense proteins is increased in response to exercise training
in mice and humans (165, 241). ROS seem to be necessary for
induction of both manganese SOD (MnSOD) and GPx gene
expression in rodents (128) and human skeletal muscle (284,
301), but the source (s) of ROS are again unclear. A recent
study found that mouse skeletal muscle responded to a single
bout of swimming exercise or electrical stimulation in iso-
lated fibers by increasing MnSOD and GPx gene transcription
(140). The exercise-induced MnSOD and GPx mRNA upre-
gulation were prevented by the NOX2 inhibitors APO or
gp91ds-tat. Later, catalase protein levels were found to in-
crease in WT, but not in ncf1* muscles after 6 weeks of
treadmill exercise training (139). This indicates that NOX2 is
required to increase the expression of some antioxidant de-
fense proteins in response to endurance exercise
Less attention has been given to the effect of exercise on
ROS-producing enzymes. However, rats selectively bred for
high running capacity show increased ROS production ca-
pacity without signs of oxidative damage (318, 354), sug-
gesting that the capacity for both ROS production and
clearance is increased by exercise training. In agreement with
an increased capacity for ROS production, a rat study showed
an increase in microsomal NOX2 activity and NOX2 mRNA
levels after a 3-week treadmill exercise training program in
gastrocnemius muscle (220). Hord et al. also found NOX2
expression to respond to exercise training in a rat study where
11 weeks of voluntary activity increased p67phox and
p47phox protein levels in skeletal muscle (152). Interest-
ingly, a 3-week training study also increased NOX4 mRNA in
rat soleus but not gastrocnemius muscle, indicating a poten-
tial fiber/muscle-type dependence of NOX isoform adapta-
tion to exercise training (220).
Overall, these data suggest that NOX2-dependent ROS
production capacity is increased by exercise training
(Fig. 11). However, whether the increased NOX2 expression
with training actually increases maximal ROS production
capacity and the physiological significance of this needs to be
further tested. Further, the effect of different exercise training
regimens on skeletal muscle NOX2 expression and activity,
particularly in humans, is presently unclear.
V. NOX2 in Skeletal Muscle Pathophysiology
A. Insulin and NOX2 in healthy skeletal muscle
In the postprandial state, hyperglycemia is sensed by pan-
creatic b cells, resulting in the secretion of insulin. In insulin-
responsive fat and muscle cells, insulin stimulates GLUT4
mobilization from intracellular compartments to the cellular
surface to promote glucose uptake and it further stimulates the
intracellular glucose storage and oxidation. Skeletal muscle
plays a quantitatively large role in whole-body glucose ho-
meostasis and accounts for *80% of whole-body glucose
disposal under hyperinsulinemic-euglycemic clamp condi-
tions (79). Interestingly, activation of different NOX isoforms
has been suggested to modulate insulin action in muscle in
both physiological and pathological contexts, as detailed later.
Studies in the 1970s explored the insulin-like effects of
pro-oxidants in adipocytes. Czech and Fain demonstrated
that thiols interacting with Cu2+ could transfer electrons to
intracellular targets and increase glucose transport in rat ad-
ipocytes (73). Subsequent work by Livingston et al. showed
that the insulin-mimetic effect of polyamines on glucose
transport in adipocytes was mediated by H2O2 generation
(213). Also, insulin was shown to generate endogenous H2O2
in adipocytes (257). Later, insulin-mediated H2O2 production
was proposed as a second messenger mediating insulin-
mediated glucose transport (232) and lipid synthesis (233) in
rat adipocytes. Subsequently, Mahadev et al. (224) reported
that genetic deletion of NOX4 reduced insulin-stimulated
glucose uptake via upregulation of the activity of cellular
protein-tyrosine phosphatases in 3T3-L1 adipocytes.
Although less studied in skeletal muscle models, insulin
stimulation was also shown to increase H2O2 levels in L6 rat
myotubes, and this increase was partially blocked by APO,
p47phox siRNA, and gp91ds-tat (67, 101). This suggests that
insulin increases NOX2-dependent H2O2 production in skel-
etal muscle, although this needs to be verified in adult muscle
models.
Downstream of insulin-stimulated NOX2, two potential
mechanisms have been proposed to transduce the redox
signal, reversible inactivation of phosphatases (120), and
stimulation of Ca2+ transients (66).
The first possibility, tyrosine phosphatase inhibition, is
proposed to lower the rate of de-phosphorylation of the in-
sulin receptor and its substrates to enable/enhance insulin
signaling, and it has yet to be directly tested in skeletal
muscle. However, in 3T3-L1 adipocytes and HepG2 cells,
insulin-stimulated H2O2 generation was reported to oxidize a
conserved redox-sensitive Cys residue within the catalytic
site of PTP1B to reversibly inhibit its activity (225). Skeletal
muscle expresses several PTP1 isoforms (11). Further,
overexpression and deletion of PTP1B in mouse muscle
impairs and increases insulin signaling and insulin sensitiv-
ity, respectively (99, 392). Interestingly, human skeletal
muscle from insulin-resistant subjects displayed increased
PTP1B activity in skeletal muscle compared with insulin-
sensitive controls (11). Thus, insulin-stimulated NOX2-
dependent inactivation of PTP1 isoforms in skeletal muscle is
an attractive hypothesis that deserves testing.
The second suggested mechanism involves insulin-
stimulated Ca2+ signals in skeletal muscle triggered by H2O2
(314). Insulin is known to evoke transient Ca2+ waves in the
proximity of the plasma membrane, but not globally, in mouse
skeletal muscle (47). The insulin-stimulated Ca2+ spikes occur
as a result of both extracellular Ca2+ entry (47) and SR Ca2+
release (67, 101). Interestingly, in cultured rat L6 myotubes, the
knockdown of the p47phox subunit markedly reduced insulin-
stimulated Ca2+ signals (101). Mechanistically, studies in
cultured muscle cells have indicated that NOX2-derived H2O2
glutathionylates the RyR1 (144) to augment insulin-stimulated
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RyR-mediated Ca2+ release (67). However, whether the local
insulin-stimulated Ca2+ transients depend on NOX2 in adult
muscle requires further testing.
B. NOX2 and insulin-stimulated muscle glucose
transport
In L6 myotubes, insulin-stimulated GLUT4 translocation
was significantly reduced by gp91ds-tat and silencing of
p47phox in a pathway requiring NOX2-stimulated Ca2+ release
from RyR1 (67). Similarly, overexpression of a dominant-
negative mutant of the NOX2 subunit Rac1 reduced insulin-
stimulated GLUT4 translocation in L6 muscle cells (181). The
muscle-specific deletion of Rac1 reduced insulin-stimulated
GLUT4 translocation (355), induced mild whole-body glucose
intolerance, and reduced muscle insulin-stimulated glucose
transport ex vivo and in vivo (293, 340). The mechanism by
which Rac1 regulates insulin-stimulated GLUT4 translocation
and glucose transport has mainly been proposed to involve actin
cytoskeleton remodeling (60). Consistent with the involvement
of the actin cytoskeleton, pharmacological disruption of the
actin cytoskeleton by Latrunculin B reduced insulin-stimulated
glucose transport in rodents (234, 342). However, the cyto-
plasmic b- and c-actin isoforms believed to undergo insulin-
stimulated actin remodeling are downregulated during muscle
differentiation (223). Further, muscle-specific KO of b-actin,
likely a major isoform involved in actin remodeling in L6
myotubes, does not reduce insulin-stimulated glucose transport
in adult mouse skeletal muscle ex vivo (223). Although actin
polymerization is regulated by glutathionylation (371), the rel-
ative contribution of NOX2 versus actin remodeling and their
potential crosstalk in mediating insulin-stimulated GLUT4
translocation, in particular in the context of adult skeletal
muscle, needs to be systematically investigated. The various
pathways proposed to involve NOX and ROS production in
insulin signaling are depicted in Figure 12.
The proposition that ROS production could mediate the
effect of acute exercise to increase muscle insulin sensitivity,
defined as a greater insulin signaling or biological endpoint
response at a given submaximal dose of insulin, has also been
put forward. It is known that prior acute contractile activity
increases the insulin sensitivity of the muscle in the hours
after exercise (297). Antioxidant ingestion to attenuate ROS
appears to blunt the acute postexercise increase in insulin
sensitivity in humans (129). Some studies interfering with
specific antioxidant defense enzymes such as Gpx1 also sup-
port a link between specific H2O2 and increased insulin sig-
naling and glucose uptake into skeletal muscle (217). However,
NOX2 does not appear to mediate acute insulin sensitization by
exercise, since muscle-specific Rac1 KO mice were fully ca-
pable of improving their whole-body insulin sensitivity and
insulin-stimulated glucose uptake measured 1h after a treadmill
running bout (344). Rather, muscle insulin sensitization by
contraction ex vivo and in situ in mice appears to require AMPK
activity (188). How this relates to the reported dependence on
ROS in humans (129) is currently unclear.
Exercise training also sensitizes skeletal muscle to insulin,
but this is believed to rely on partly distinct mechanism in-
volving increased capillarization, GLUT4, and hexokinase
expression (343). It is unsettled whether ROS play a role in
the exercise-training induced insulin sensitivity, since this
effect was diminished by dietary antioxidants in some (301)
but not other studies (390). NOX isoforms have, to our
knowledge, not been studied in this context.





which inhibits tyrosine phos-
phatases (PTP1B, PTEN, and
PP2A) augmenting insulin-
stimulated phosphorylation in
skeletal muscle. Rac1 can act
potentially by the actin cyto-
skeleton and NOX2 to induce
GLUT4 translocation to the
plasma membrane. IR, insulin
receptor; IRS, insulin receptor
substrate; PP2A, protein phos-
phatase 2A; PTEN, phospha-
tase and tensin homolog;
PTP1B, protein tyrosine phos-
phatase 1B; RyR, ryanodine
receptor; SR, sarcoplasmic re-
ticulum. Color images are
available online.
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C. Redox signaling in muscle insulin resistance
Skeletal muscle insulin resistance, the inability of cells to
efficiently respond to stimulation by insulin, is an early and
causative event in the etiology of type 2 diabetes (T2D) (79).
Left untreated, skeletal muscle insulin resistance is a major
risk factor for T2D and cardiovascular disease (2). Excess
weight is a well-established risk factor for T2D, with*80%
of type 2 diabetics being overweight (171). Consequently,
much effort has gone into mechanistically understanding
how obesity causes insulin resistance in insulin-responsive
tissues, including muscle. Currently, obesity is believed to
drive the development of insulin resistance in skeletal muscle
via a complex etiology involving multiple instigators, in-
cluding gut-derived endotoxins and microbial products (130),
low-grade inflammation (203), and ectopic lipid deposition
causing lipotoxicity (326).
Increased cellular damage by ROS has long been linked to
insulin resistance downstream of these insults (Fig. 13). For
instance, humans in the early stages of the metabolic syndrome,
that is, carrying a cluster of risk factors for macrovascular
disease including impaired glucose tolerance, show elevated
lipid peroxidation markers in plasma (178). A close relation-
ship (r= 0.668, p< 0.01) between insulin resistance and oxi-
dative stress markers has also been reported in obese subjects
(356), suggesting maybe a causal relationship. Indeed, a highly
pro-oxidative intracellular environment is well described as
disrupting insulin signal transduction in multiple models of
insulin-responsive tissues, including adipose cells (154), liver
(123), and skeletal muscle cells (163).
Analogous to exercise-induced ROS, mitochondria were
first proposed as the major source of O2
$-/H2O2 in relation to
insulin resistance (17, 148). However, time course studies in
rodents subsequently showed that insulin resistance occurred
before mitochondrial dysfunction (39). Further, studies using
pharmacological or genetically encoded antioxidants targeted
at mitochondrial O2
$-/H2O2 to prevent mitochondrial ROS-
induced insulin resistance have generated mixed results (83).
Consequently, mitochondrial ROS are increasingly believed
to be modulators rather than initiators of insulin resistance
(Fig. 13) (83).
Interestingly, obesity is characterized by increased NOX2
subunit expression in adipose tissue (117), skeletal muscle
(100), and vasculature (166). For instance, Espinosa et al.
(100) demonstrated that the p47phox protein expression was
nearly 7-fold, and the NOX2 subunit was 1.6-fold higher in
tibialis anterior (TA) muscle from high-fat diet-fed mice
versus controls. This was accompanied by augmented
insulin-stimulated cytosolic H2O2 measured by using the
HyPer probe in FDB fibers. The mechanism of increasing
FIG. 13. Role of NOX- and mitochondria-derived O2
$-/H2O2 in muscle insulin resistance. Illustration of how ROS-
dependent and -independent mechanisms may contribute to obesity-associated muscle insulin resistance. NOX2 expression and
activity are increased by several insulin-resistance-promoting endocrine signaling factors, including endotoxins, pro-inflammatory
factors, and more. AT II is included as an example of the latter, acting to increase NOX2-dependent ROS generation to disrupt the
insulin signaling cascade and increase lipid peroxidation. Akt, protein kinase B; AT II, angiotensin II; DAG, diacylglycerol; IKK,
I kappa B kinase; iNOS, inducible nitric oxide synthase; JNK, c-Jun NH2-terminal protein kinase; PI3K, phosphatidylinositol 3
kinase; sFFA, free fatty acids; TAG, triacylglyceride; TLR, Toll-like receptor. Color images are available online.
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NOX2 expression is unclear. However, NOX2 is well known
to be increased by obesity-linked disease mediators, includ-
ing endotoxin signaling via Toll-like receptor 4 (237, 238)
and nucleotide-binding oligomerization domain (210), pro-
inflammatory cytokines (208, 391), fatty acids (168), pro-
fibrotic transforming growth factor type b1 (TGF-b1) (212),
lysophosphatidic acid (359), and angiotensin II (AT II). It
should be noted that many of these factors have also been
linked to muscle atrophy and that obesity-associated muscle
atrophy is known to exacerbate sarcopenia (172). For in-
stance, Ang-II, suggested to induce muscle atrophy via
NOX2 (4, 63), also caused insulin resistance in incubated rat
soleus muscles via a mechanism partially alleviated by the
antioxidant tempol (84). Thus, a contribution of NOX2-
mediated oxidative stress might be speculated to be a con-
tributor to both skeletal muscle insulin resistance and atrophy.
The role of NOX2 in muscle insulin resistance is unclear
since no studies have inhibited skeletal muscle NOX2 alone
and measured this endpoint (Table 2). Most studies in
whole-body NOX2 KO mice and pharmacological inhibi-
tion generally report a protective phenotype against whole-
body glucose intolerance and insulin resistance (Table 2),
with one notable exception (68). Since myeloid-specific
NOX2 KO mice present a similar protective phenotype
(280), the protective phenotype in many of the whole-body
NOX2 KO studies probably involves decreased inflamma-
tory signaling, consistent with NOX2-dependent oxidative
stress contributing to muscle insulin resistance. It is worth
noting that the C57BL/6J-m obese diabetic mouse model
and db/+ carry a point mutation in the p47phox gene, which
results in aberrant splicing of the p47phox transcripts and,
consequently, loss of NOX2 function (155). This might
contribute to the phenotype in these mice, otherwise at-
tributed to leptin receptor deficiency (394).
It should be evident from what has been mentioned that the
study of ROS-mediated muscle pathology has moved from a
simplified redox-hormetic concept, where global ROS dos-
age is the only determinant of detrimental effects (Fig. 14A),
to an increasingly nuanced working model, considering also
the specific subcellular ROS sources that play an important
role (Fig. 14B), with H2O2 generation in specific compart-
ments being either beneficial or detrimental. In line with the
latter, NOX2 has gained increasing attention as a potential
compartment-specific mediator of insulin resistance. Studies
in whole-body NOX2 KO studies are generally supportive of
the concept of NOX2-dependent oxidative stress as a medi-
ator of insulin resistance, but they make firm conclusions
about the role of NOX2 in muscle impossible. Currently, the
only muscle-specific NOX2-deficient mouse model is the
Rac1 KO mouse, but Rac1 has many NOX2-independent
signaling functions, notably regulation of insulin-stimulated
actin remodeling and GLUT4 translocation (60), making it
hard to evaluate the role of skeletal muscle NOX2 as a driver
of insulin resistance in this tissue. Future studies need to
generate and characterize other muscle-specific NOX2 sub-
unit KO mouse models to clarify this.
D. Altered redox signaling in muscular dystrophies
Muscular dystrophies represent a heterogeneous group of
genetic diseases affecting skeletal muscle in both children and
adults and are characterized by skeletal muscle weakness,
wasting, and degeneration, with Duchenne muscular dystrophy
(DMD) being the most severe (322). DMD is an X-linked
disease that affects between one in 3600 and 6000 live male
births (48). At the molecular level, DMD is characterized by a
severe reduction or absence of the protein dystrophin (189) and
this absence causes the rupture of the sarcolemma of the muscle
fiber during contraction (12). At the cellular level, muscle tis-
sue of DMD patients shows evidence of degeneration, regen-
eration, myofiber atrophy, fatty accumulation, necrosis of
muscle fibers, inflammation, and fibrosis (16, 321, 361).
The most studied animal model of DMD is the mdx mouse,
which presents a less severe phenotype than human DMD
patients (1). NOX2 is upregulated in the mdx mouse, and this
is a potential contributor to oxidative stress and DMD pa-
thology (179, 375, 381). In this context, an increase in the
complex subunits NOX2, p67phox, and Rac1 was reported in
TA muscle from mdx mice compared with WT (377). Inter-
estingly, the increased expression of NOX2 subunits pre-
ceded muscle necrosis and inflammation, suggesting that
NOX2 complex may be a crucial source of oxidative stress
triggering these events in mdx mice (1).
One of the main occurrences related to the deleterious
effects observed in dystrophic muscle is Ca2+ influx to ele-
vate cytosolic Ca2+ (119, 376). It has been demonstrated that
Ca2+ influx through either nonspecific plasma membrane
damage (250) or increased facilitated transport by stretch-
activated channels (SACs) such as transient receptor poten-
tial channel 1 (TRPC1) (13) induces muscle-cell damage in
the mdx mice. Another candidate for mediating the chronic
elevation in intracellular Ca2+ concentrations in dystrophic
skeletal muscle is a store-operated Ca2+ channel (95, 201).
Meanwhile, basal Ca2+ release from the SR also appears to be
increased (14). Both IP3 receptors and ryanodine receptors
seem to be involved in this SR Ca2+ release, which has been
suggested to increase NF-jB transcriptional activity, induc-
ible nitric oxide synthase expression, and reactive nitrogen
species. In fact, when the basal Ca2+ levels were restored by
nifedipine injection, mdx muscles recovered their functional
capacity (15). Regarding the downstream mechanism in-
volved in the damage induced by the Ca2+ influx, the par-
ticipation of TRPC1, caveolin-3, and Src-kinase has been
documented. Thus, TRPC1, caveolin-3, and Src-kinase pro-
tein levels were increased in mdx muscle compared with WT
(126). This is relevant, because caveolin-3 colocalized and
coimmunoprecipitated with TRPC1, suggesting an interac-
tion between these proteins that is dependent on NOX2-
derived H2O2 with the participation of Src-kinase (126).
Moreover, the activation and localization of TRPC1 is
caveolin-3-dependent (126). Also, NOX2 may show in-
creased sensitivity to mechanical stress in dystrophic muscles
(376), and recent evidence indicates that NOX2 is activated by
stretch and contributes to muscle damage in the TA of mdx
mice (377). It has been described that in dystrophic single
muscle fibers the excessive O2
$- production derived from
NOX2, and the simultaneous activation of abnormal Ca2+
signals amplify each other to produce a vicious cycle of
damaging events, which may contribute to the abnormal me-
chanical stress sensitivity (325). Interestingly, nonspecific
pharmacological inhibition of NOX2 by DPI significantly re-
duced the intracellular Ca2+ rise after stretched contractions
in mdx single fibers and attenuated the loss of muscle force
(377). In agreement, cross-breeding of p47phox KO with the
1390 HENRI´QUEZ-OLGUI´N ET AL.
Table 2. Studies Addressing the Contribution of NOX2 to Insulin Resistance
Model Intervention Phenotype compared with control Reference
Whole-body NOX2 KO mice,
C57BL/6J background,
males




Obesity protection in APO and
NOX2 KO mice. Similar food
intake, lower fasting glucose and
insulin, improved GTT
(93)
Whole-body NOX2 KO mice,
C57BL/6J background,
males, single-caged
13–18 weeks 60 E% HFD from
weaning
Hyperphagia, obesity, decreased






Whole-body NOX2 KO mice,
C57BL/6J background,
males (NOX2 KO but not
WT were sterile-housed)
14 weeks 60 E% HFD from
4 months of age
Similar body weight gain but less
vWAT and vWAT macrophage
infiltration. Lower fasting and
GTT glucose. Similar fasting
insulin.
(280)
Whole-body NOX2 KO mice,
C57BL/6J background,
males
3–9 months 45 E% HFD from
6 weeks of age
Similar body mass and composition
after HFD, lower fasting insulin
and glucose, improved GTT and
ITT, higher lean mass on HFD







5 weeks of Chow, fat-enriched (45
E% Fat) and low-fat diet (10 E%)
from 18 weeks of age
Augmented body weight, glucose
and insulin intolerance were ob-
served in p47KO mice fed with





16 weeks 60 E% HFD from 4
months of age
Lower body weight and visceral
inflammation. Lower fasting
blood glucose and insulin after
HFD
(281)




12 weeks 60 E% HFD from 8 weeks
of age
Lower body weight gain, decreased
liver and WAT mass gain, and
liver steatosis on HFD, improved





Rac1 KO mice, mixed
129Ola-C57BL/6 (CLEA,
Japan), male










KO induction at 14–18 weeks of
age. 3 weeks induction +4–6
weeks. washout before experi-
ments
Worsened GTT and ITT. Reduced
maximal insulin-stimulated glu-
cose transport in soleus and EDL
muscles ex vivo. Similar result






KO induction at 12–16 weeks s of
age. 3 weeks induction +3 weeks.
washout before experiments. 18
weeks 60 E% HFD. KO induc-
tion repeated 10 weeks into diet
study.
No effect on whole-body glucose
tolerance, body composition, or
metabolism. Decreased insulin-
stimulated glucose uptake in situ
on chow and HFD in skeletal
muscle. Improved WAT glucose
uptake under the same condi-
tions. Normal Akt phosphoryla-
tion in muscle.
(293)
Akt, protein kinase B; EDL, extensor digitorum longus; GLUT4, glucose transporter 4; GTT, glucose tolerance test; HFD, high-fat diet;
ITT, insulin tolerance test; vWAT, visceral WAT; WAT, white adipose tissue; WT, wild-type.
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dystrophic mdx mice was protective against pathological Ca2+
influx in skeletal muscle and reduced fibrosis and stiffness
(215, 216). The microtubule cytoskeleton was also less dis-
organized in p47phox-/-/mdx muscles (216), with post-
translational detyrosination of alpha-tubulin proposed as a
mechanism that increases stiffness and thereby stretch-
stimulated NOX2 activation in dystrophic muscle (180).
Along the same lines, it has been demonstrated that in
double transgenic p47phox-/-/mdx mice the elimination of
NOX2-dependent O2
$-/H2O2 production protected against
force decrements, probably by decreasing the aberrant Ca2+
influx through the sarcolemma (270). The disorganization of
microtubules seemed to participate in the increased ROS
production mechanism observed in dystrophic muscles (216)
since stimulation by passive stretch increased microtubule-
dependent activation of NOX2 activity, which ultimately
produced the augmented Ca2+ influx through SACs in mdx
muscle (180).
NOX2 activity and increased H2O2 levels have been
linked to increased NF-jB activity (14, 54) (Fig. 15). The
presence of an activated form of NF-jB has, thus, been
demonstrated in both regenerating and necrotic fibers from
DMD muscle by Western blotting and electrophoretic mo-
bility shift assay analysis (252). In the mdx mouse, a skeletal
muscle-specific activation of NF-jB has been demonstrated
even before the onset of dystrophic damage (195). The
pharmacological inactivation of NF-jB activity by pyrroli-
dine dithiocarbamate decreased the damage in dystrophic
muscles elicited by oxidative stress, with consequent im-
provements in functional, morphological, and biochemical
parameters. Studies in vitro indicated using APO or gp91ds-
tat that electrical stimulation of primary mdx myotubes
compared with WT-controls induced an increase of NOX2-
dependent O2
$-/H2O2 production and NF-jB activation
(139). Further, increased MMP-9 expression and activity in
mdx mice was required for NF-jB activity, contributing to
the pathogenesis of the dystrophic muscle and the regulation
of regeneration (207), with MMP-9 expression also being
linked to chronic activation of NOX2 and NF-jB activation
in multiple cell types (182, 353).
Another NOX2-dependent process proposed to contrib-
ute to damage in dystrophic skeletal muscle is autophagy
(78). Hence, a recent study showed that autophagy in mdx
mouse muscle was decreased via an NOX2-dependent
mechanism (374). The decreased autophagy could be re-
stored to normal levels by the use of statins, which reduced
NOX2 expression and are also known to inhibit Rac GTPase
function by blocking the synthesis of isoprenoid interme-
diates (19, 292). Overall, this resulted in lower muscle
damage, inflammation, fibrosis, and an increase in muscle
force production (373, 374).
One of the main features of dystrophic muscles is the de-
velopment of fibrosis. Pathophysiological fibrosis is charac-
terized by an excessive accumulation of extracellular matrix
(ECM) components. Many pro-fibrogenic factors are produced
within the affected tissue, leading to the activation of fibroblasts
and the expression of ECM components and pro-fibrogenic
factors. Among them are TGF-b and AT II (49, 50, 388). TGF-
b is a potent pro-fibrotic cytokine that contributes to the path-
ogenesis of several muscular dystrophies (6, 30). Interestingly,
it has been reported that TGF-b induces its own expression in
C2C12 mouse muscle cell culture by a mechanism inhibited by
APO, suggesting a dependence on NOX2-induced ROS pro-
duction (4). Thus, TGF-b may activate an autocrine positive
feedback loop dependent on NOX2 that perpetuates the de-
velopment of fibrosis (6). This would be consistent with the
observed reduced fibrosis and stiffness in mdx mouse muscle
lacking p47phox (216).
AT II is the main peptide of the classical axis of Ras (51).
AT II is formed by the action of the angiotensin-converting
enzyme, and its main pathophysiological effects are mediated
by the angiotensin receptor type 1, which is expressed in
skeletal muscle (51). The fibrotic effects induced by AT II,
such as increased expression of fibronectin, collagen III, and
connective tissue growth factor, were dependent on the NOX2-
induced ROS production in C2C12 muscle cells (49). Also, AT
II mediates its pro-fibrotic effects via crosstalk with signaling
pathways activated by TGF-b, suggesting that several pro-
fibrotic factors shown to influence NOX2-induced O2
$-/H2O2
production may interact (4, 256).
Recent studies in mice suggested that decreasing muscle
fibrosis is a potential therapy for DMD (7, 52, 255). Based on
the studies just cited, reducing NOX2-dependent O2
$-/H2O2
production may improve pro-fibrotic signaling in dystrophic
skeletal muscle and be a potential treatment strategy for this
disease.
FIG. 14. Models explaining the paradoxical good and
bad effects of ROS in muscle function. (A) Transient ex-
posure to ROS is beneficial whereas chronic exposure to
ROS is detrimental to muscle function. This relates to the
redox hormesis concept depicted in Figure 10. (B) Com-
partmentalized local ROS generation allows the activation
of specific redox targets in the proximity of the ROS source.
This may be either beneficial or detrimental to muscle
function. Color images are available online.
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E. Potential role of NOX2 in muscle wasting
and contractile dysfunction conditions
Atrophy is a typical pathological condition observed in
skeletal muscle as a consequence of aging, disuse, starvation,
sepsis, or denervation, or secondary to different chronic
diseases such as diabetes, cancer, and kidney, lung, heart, and
liver diseases (352, 362).
The main feature of atrophy in skeletal muscle is the loss of
muscle mass due to a reduction in the myofibrillar protein
content, resulting in decreased contractile capacity and force
generation (38, 103). Relevant to this review, skeletal muscle
wasting has been mechanistically linked to oxidative stress
caused by excessive ROS production and/or decreased anti-
oxidant defense (286). This section will highlight some of the
emerging roles of NOX2 in different conditions where skel-
etal muscle wasting/dysfunction occurs.
1. Denervation and disuse-related atrophy. As dis-
cussed in several excellent reviews, a number of studies have
demonstrated that lowering ROS production by using general
or mitochondrial-targeted antioxidants inhibited the upregu-
lation of proteolytic pathways and muscle atrophy induced by
disuse or denervation (122, 288). Similarly, denervation at-
rophy in mice and fasting in C2C12 myotubes is associated
with increased ROS production in mice and is suggested to be
sensitive to antioxidant-treatment (290). Given the estab-
lished role of NOX2 in other kinds of muscle wasting, it is
tempting to speculate that NOX2 is a shared contributing
ROS source in response to denervation, disuse, or starvation,
despite these atrophy paradigms eliciting partially distinct
molecular signaling (46, 245).
The specific role of NOX2 remains largely uninvestigated
in these contexts. However, Scalabrin et al. (312) studied the
effect of prolonged surgical denervation on peroxide release
and proteins that regulate redox homeostasis in murine
muscle fibers. Together with increased mitochondrial H2O2
production, denervation upregulated NOX subunits such as
p67phox, p40phox, and NOX2 within a 21-day period. In
addition, APO reduced mitochondrial H2O2 in denervated
skeletal muscle fibers, which might imply communication
between mitochondrial and cytosolic ROS (i.e., NOX2)
sources (Fig. 16). Confirming these findings, a recent study
showed increased protein levels of NOX2 and NOX4 after
spinal cord injury in human patients. The upregulation of
NOX2 and NOX2 was accompanied with increased procas-
pase 3 protein levels, suggesting that altered redox state could
drive myocelullar apoptosis in human muscle (311).
2. Aging-related sarcopenia. In most mammalian spe-
cies, including humans, aging is associated with a reduction
in skeletal muscle mass and function termed sarcopenia.
Sarcopenia is characterized by atrophy of the constituent
muscle fibers, displaying larger atrophy of fast-twitch type 2
compared with slow-twitch type 1 fibers, with increased
FIG. 15. NOX2-dependent O2
$-/H2O2 production in inflammatory and necrotic signaling pathways in Duchenne
muscular dystrophy. The interaction between NOX2 and mitochondrial ROS and Ca2+ signaling in dystrophic muscle.
Ca2+dysregulation is related to elevated NF-jB activity and iNOS. Both NO and ROS contribute to an increase in Ca2+ leak
from the SR and extracellular Ca2+entry. NO, nitric oxide; PTP, protein tyrosine phosphatases. Color images are available
online.
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heterogeneity in fiber size, and an increase in noncontractile
(adipose and connective) tissues within the muscles (302).
Animal studies suggest the involvement of ROS in the
development of sarcopenia. Similar to other models in which
atrophy occurs, ROS production measured as dihy-
droethidium (DHE) fluorescence, and H2O2 in skeletal
muscle homogenates of a mouse sarcopenia model were in-
creased with aging, concurrent with increased mRNA ex-
pression of NOX2 subunits and NOX4 and changes in
antioxidant defense enzymes (337). However, a recent series
of studies comparing KO mice with specific deletion of
SOD1 in nerves, muscle fibers, or globally demonstrated that
the loss of SOD1 in either motor neurons or muscle fibers
alone produced only mild phenotypic changes and did not
recapitulate the sarcopenic phenotype of global SOD1 KO
mice (308). In contrast, the crossing of the global SOD1 KO
with a transgenic synapsin-1 promotor-driven SOD1 over-
expression mouse to partially restore nerve SOD1 expression
was sufficient to preserve both NMJ and skeletal muscle
morphology and function (309). Taken together, these studies
suggest a critical role of redox status in motor neurons in the
development of sarcopenia, which subsequently affects
skeletal muscle to further perpetuate NMJ damage in a neg-
ative feedback loop. Notably, sarcopenia in the global SOD1
KO model occurred without changes in markers of oxidative
stress such as protein carbonyls and 4-hydroxy-2-nonenal in
peripheral nerves (308), suggesting that disturbances in spe-
cific redox signaling pathways rather than unspecific oxida-
tive stress resulted in the sarcopenic phenotype.
The role of NOX2 in aging-induced sarcopenia is currently
controversial. NOX2 is expressed in both neurons and muscle
fibers. Interestingly, SOD1, the protein deleted in the sarco-
penia model just cited (308), is the most commonly mutated
protein in familial amyotrophic lateral sclerosis (ALS), a
disease associated with fatal degeneration of cortical and
spinal motor neurons. In a mouse model of ALS expressing
mutated SOD1 G93A, deletion of NOX1 and, in particular,
NOX2 impeded disease progression and enhanced survival
(227). In a follow-up study, SOD1 was proposed to directly
bind Rac1 and inhibit its GTPase activity in a manner dis-
rupted by oxidation of Rac1 by H2O2 (136). Mutations in
SOD1 were proposed to decrease this redox-sensitive un-
coupling to increase NOX2 activity in ALS neurons (136).
Consistent with the role of NOX2, pharmacological blockade
of NOX2 by APO increased the average life-span of the
SOD1 G93A mutant mouse ALS model (136). However, an
independent follow-up study found no effect of either NOX1
or NOX2 KO or broad-spectrum pharmacological NOX in-
hibition by perphenazine and thioridazine on the survival of
the SOD1 G93A ALS mouse model, despite an evident re-
duction in O2
$- levels in vivo (320). This makes the role of
NOX2 in ALS unclear and hard to generate a clear hypoth-
esis regarding the role of NOX2 in aging neurons.
Apart from a possible role in motoneurons, NOX2 might
play a role in the secondary development of sarcopenia-
associated muscle atrophy. Studies of wheel-running exercise
training and 8% calorie restriction in young versus aged rats
suggest that NOX2 subunit expression in skeletal muscle
decreased with aging and that either calorie restriction alone
or calorie restriction + exercise training prevented this de-
crease and aging-associated muscle atrophy (152). Although
this does not seem to fit the generic NOX2-oxidative stress-
muscle dystrophy/atrophy model, decreased NOX2 subunit
expression in conjunction with decreased antioxidant defense
may result in an increased net oxidative stress, as reported in
a cancer cachexia mouse model (336). Consistent with such a
scenario, previous measurements of total hydroperoxides in
the rat wheel-running exercise and 8% calorie-restriction
sarcopenia study suggested increased oxidative stress with
increasing age, which was attenuated by combined caloric
FIG. 16. Upregulation of NOX2 in-
duced by different atrophic factors.
NOX2 is activated by various forms of
atrophy induced by both circulating and
neuromuscular factors. Preliminary evi-
dence suggests crosstalk between mito-
chondria and NOX2, inducing altered
redox signaling. Color images are avail-
able online.
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restriction and exercise (185). More studies are needed to
verify the decreased NOX2 expression in aging skeletal
muscle and tease out the role of NOX2 activity, if any, in the
development of sarcopenia.
3. Circulating factors mediating muscle atrophy and con-
tractile dysfunction. There is some evidence suggesting that
NOX2 activity can be upregulated by blood-borne factors
linked to muscle atrophy (Fig. 16). For instance, a recent study
of cardiac cachexia in a rat model of heart failure (HF) dem-
onstrated increased NOX2 and p47phox protein expression
and NOX2 activity in isolated membrane fractions accompa-
nied by NF-jB activation and increased p38 phosphorylation
and atrophy of glycolytic plantaris muscle. In this model, the
muscle wasting and the NOX2 complex activity were reduced
by 8 weeks of treadmill exercise training, suggesting that
NOX2 may be a good candidate drug target for treating cardiac
cachexia and perhaps other types of muscle wasting (72). In
contrast, a study investigating mouse cancer cachexia reported
decreased mRNA expression of multiple NOX2 subunits and
antioxidant defense enzymes commensurate with increased
DHE fluorescence in skeletal muscle (336), suggesting that
decreased antioxidant defense rather than increased NOX2
activity caused oxidative stress in that model.
Among the potential atrophic factors, a term used for ex-
tracellular soluble factors eliciting skeletal muscle atrophy
(51), is AT II. This hormone has been implicated in the pa-
thology of conditions such as cardiac failure and kidney
disease-related muscle atrophy (18). The relationship between
AT II and NOX2 in skeletal muscle has been evaluated by
different researchers (69, 169). One study suggested using
pharmacological inhibitors that AT II signals via NOX2 to
increase intracellular Ca2+ in mouse EDL skeletal muscle fibers
(69). Experiments in vitro using C2C12 myotubes indicated
that AT II increased the ROS production by a DPI-inhibitable
NOX2-dependent mechanism (305). In mouse models of
AT II-dependent muscle atrophy, elevated p47phox mRNA
expression was observed in parallel to decrease in SOD1 and
catalase mRNA (254). In experiments infusing Ang-II via
osmotic minipumps for 7 days, an NOX2-dependent increase
in ROS levels and muscle atrophy was observed in p47phox
KO mice (319), demonstrating the necessity of NOX2 activity
in the atrophic process induced by AT II (319). This is con-
sistent with another recent study in NOX2 KO mice where the
KO mice compared with WT were strongly protected against 4
weeks of AT II infusion-induced skeletal muscle atrophy and
associated changes in anabolic and catabolic signaling (169).
TGF-b1, in addition to inducing fibrosis in skeletal
muscle, also promotes muscle fiber atrophy (239). It was
recently demonstrated that TGF-b, through its receptor
ALK5, activated both canonical and noncanonical TGF-b
signaling pathways in mouse skeletal muscle (6), and likely
induced muscle atrophy by an NOX2-dependent mecha-
nism, evidenced by its inhibition by APO (4, 5). Besides,
TGF-b-stimulated NOX2-dependent ROS production was
upstream of Smad, ERK, and c-Jun NH2-terminal protein
kinase pathways that were necessary for the atrophic effect
mediated by TGF-b (6).
The association between inflammation and contractile dys-
function has been linked to elevated sphingomyelinase activity
in patients with chronic HF (92). Exogenous sphingomyelinase
stimulation results in an increase in ceramide generation in
skeletal muscle cells and mouse diaphragm muscle in a redox-
dependent manner (106). Moreover, sphingomyelinase-
induced ROS is involved in the reduction in muscle force in
mouse muscle fibers (107). Loehr et al. studied the subcellular
source contributing to sphingomyelinase-mediated ROS pro-
duction and contractile dysfunction (214). Using intact FDB
muscle fibers, this study showed that sphingomyelinase in-
creased NOX2-dependent O2
$-/H2O2 generation and had no
effect on mitochondrial oxidants. Moreover, the incubation
with gp91ds-tat or genetic deletion of either NOX2 or
p47phox conferred protection against decreased force pro-
duction induced by sphingomyelinase (41, 214). Together,
these studies demonstrated that NOX2 plays a central role in
sphingomyelinase-mediated ROS production and contractile
dysfunction associated with inflammatory states.
VI. Conclusions and Future Directions
In this review, we have attempted to provide a comprehensive
overview of what is currently known about the regulation and
function of NOX2 in skeletal muscle and areas where our
knowledge is still highly limited. In general, the working models
regarding the various functions of ROS in muscle have expanded
from a simplified redox-hormetic concept, where global ROS
dosage is the sole determinant of biological effects (Fig. 14A), to
an increasingly nuanced working model, where specific sub-
cellular redox-signaling events determine biological effects
(Fig. 14B), with H2O2 generation in specific compartments be-
ing either beneficial or detrimental. In line with the latter, NOX2
has gained increasing attention as a potential compartment-
specific mediator of insulin resistance. Studies in whole-body
NOX2 KO studies are generally supportive of the concept of
NOX2-dependent oxidative stress as a mediator of insulin re-
sistance but they make firm conclusions about the role of NOX2
in muscle impossible. It should be evident that the knowledge
gaps are distributed across many aspects of skeletal muscle
NOX2 signal transduction. Major outstanding questions in
skeletal muscle include where NOX2 complex assembly occurs,
how NOX2 is regulated, how ROS generated by NOX2 reach
the cytosol, what signals are downstream of NOX2, whether the
signal transduction differs between health and disease, the re-
quirement of NOX2 for different physiological and pathophys-
iological processes, and perhaps, most importantly, whether the
proposed functions of NOX2 in cells and animal models are
conserved into humans. Already, however, it appears from the
literature that NOX2-mediated ROS production is involved in a
large number of processes in skeletal muscle fibers, including
exercise metabolism, gene regulation, insulin action, and muscle
mass regulation. Uncovering the exact underlying mechanisms
might allow the development of novel treatment and prevention
strategies against major lifestyle and aging-associated muscle
diseases such as insulin resistance and atrophy.
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Abbreviations Used
AD¼ activation domain
Akt¼ protein kinase B




AT II¼ angiotensin II
ATM¼ ataxia telangiectasia mutated kinase
Ca2+¼ calcium








EDL¼ extensor digitorum longus
ERK¼ extracellular signal-regulated protein kinase
FDB¼ flexor digitorum brevis
GDI¼ guanosine nucleotide dissociation
inhibitor
GEFs¼ guanine nucleotide exchange factors
















NADPH¼ nicotinamide adenine dinucleotide
phosphate
NDPK¼ nucleoside diphosphate kinase
NF-jB¼ nuclear factor-jB
NOX¼NADPH oxidase
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Abbreviations Used (Cont.)
Nrf2¼ nuclear factor erythroid
2–related factor
PAK¼ p21-activated kinases
PB1¼Phox and Bem 1
PI3P¼ phosphatidylinositol 3-phosphate
PKC¼ protein kinase C
PRR¼ proline-rich region
Prx¼ peroxiredoxin




ROS¼ reactive oxygen species




STAT3¼ signal transducer and activator
of transcription 3
T2D¼ type 2 diabetes
TA¼ tibialis anterior
TGF-b¼ transforming growth factor type b
TPR¼ tetratricopeptide repeat
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